Section 50

EurekaMag PDF full texts Chapter 49,676


Westfall, T.C. 2006: Neuropeptide y and sympathetic control of vascular tone in hypertension. Exs 95: 89-103
Tsuda, K. 2003: Neuropeptide Y and sympathetic nervous system in blood pressure regulation. Hypertension 42(5): E13
Edvinsson, L. 2006: Neuropeptide y and the cerebral circulation. Exs 95: 105-112
Feuerstein, G.Z.; Lee, E.W. 2006: Neuropeptide y and the heart: implication for myocardial infarction and heart failure. Exs 95: 113-122
Zoccali, C. 2005: Neuropeptide y as a far-reaching neuromediator: from energy balance and cardiovascular regulation to central integration of weight and bone mass control mechanisms. Implications for human diseases. Current Opinion in Nephrology and Hypertension 14(1): 25-32
Soscia, S.J.; Harrington, M.E. 2005: Neuropeptide y does not reset the circadian clock in NPY Y2-/- mice. Neuroscience Letters 373(3): 175-178
Nan, Y.-S.; Feng, G.-G.; Hotta, Y.; Nishiwaki, K.; Shimada, Y.; Ishikawa, A.; Kurimoto, N.; Shigei, T.; Ishikawa, N. 2004: Neuropeptide y enhances permeability across a rat aortic endothelial cell monolayer. American Journal of Physiology. Heart and Circulatory Physiology 286(3): H1027-H1033
Heredia, M.ía.d.P.; Delgado, C.; Pereira, L.; Perrier, R.; Richard, S.; Vassort, G.; Bénitah, J.-P.; Gómez, A.M.ía. 2005: Neuropeptide y rapidly enhances [Ca2+]i transients and Ca2+ sparks in adult rat ventricular myocytes through Y1 receptor and PLC activation. Journal of Molecular and Cellular Cardiology 38(1): 205-212
Hammond, M. 2001: Neuropeptide y receptor antagonists. Idrugs: the Investigational Drugs Journal 4(8): 920-927
Gehlert, D.R.; Hipskind, P.A. 1997: Neuropeptide y receptor antagonists in obesity. Expert Opinion on Investigational Drugs 6(12): 1827-1838
Rosmaninho-Salgado, J.; Alvaro, A.Rita.; Grouzmann, E.; Duarte, E.P.; Cavadas, Cáudia. 2007: Neuropeptide Y regulates catecholamine release evoked by interleukin-1beta in mouse chromaffin cells. Peptides 28(2): 310-314
Zheng, J.; Zhou, G.; Hexum, T.D. 2000: Neuropeptide y secretion from bovine chromaffin cells inhibits cyclic AMP accumulation. Life Sciences 67(6): 617-625
Tsurumaki, T.; Honglan, P.; Higuchi, H. 2003: Neuropeptide y selectively potentiates alpha1-adrenoceptor-mediated contraction through Y1 receptor subtype in rat femoral artery. Journal of Cardiovascular Pharmacology 42(Suppl 1): S33-S37
Morris, M.J.; Gannan, E.; Stroud, L.M.; Beck-Sickinger, A.G.; O'Brien, T.J. 2007: Neuropeptide Y suppresses absence seizures in a genetic rat model primarily through effects on Y receptors. European Journal of Neuroscience 25(4): 1136-1143
Lall, G.S.; Biello, S.M. 2003: Neuropeptide Y, GABA and circadian phase shifts to photic stimuli. Neuroscience 120(4): 915-921
Ramos, E.J.B.; Meguid, M.M.; Campos, A.C.L.; Coelho, J.C.U. 2005: Neuropeptide Y, alpha-melanocyte-stimulating hormone, and monoamines in food intake regulation. Nutrition 21(2): 269-279
Wójcik-Gładysz, A.; Polkowska, J. 2006: Neuropeptide Y--a neuromodulatory link between nutrition and reproduction at the central nervous system level. Reproductive Biology 6(Suppl 2): 21-28
Zukowska, Z.; Grant, D.S.; Lee, E.W. 2003: Neuropeptide Y: a novel mechanism for ischemic angiogenesis. Trends in Cardiovascular Medicine 13(2): 86-92
Pons, J.; Lee, E.W.; Li, L.; Kitlinska, J. 2004: Neuropeptide Y: multiple receptors and multiple roles in cardiovascular diseases. Current Opinion in Investigational Drugs 5(9): 957-962
Hill, R.G.; Oliver, K.R. 2007: Neuropeptide and kinin antagonists. Handbook of Experimental Pharmacology 177: 181-216
Fehér, E.éb. 2004: Neuropeptide containing nerve fibres in the liver. Orvosi Hetilap 145(34): 1759-1763
Nasu, T.; Sueishi, A.; Morimoto, M. 2003: Neuropeptide distribution in the stellate ganglia of the domestic animal. Fukuoka Igaku Zasshi 94(12): 338-346
Attademo, A.M.; Rondini, T.A.R.; Rodrigues, B.C.; Bittencourt, J.C.; Celis, Mía.Ester.; Elias, C.F. 2006: Neuropeptide glutamic acid-isoleucine may induce luteinizing hormone secretion via multiple pathways. Neuroendocrinology 83(5-6): 313-324
Russell, J.A.; Ueta, Y. 2004: Neuropeptide hormones and stress. Stress 7(2): 73-74
Mendonça, J.C.d.; Dolci, J.é E.L. 2005: Neuropeptide immunofluorescence in human nasal mucosa: assessment of the technique for vasoactive intestinal peptide (VIP). Brazilian Journal of Otorhinolaryngology 71(2): 123-131
Belokoskova, S.G.; Tsikunov, S.G.; Klement'ev, B.I. 2002: Neuropeptide induction of compensatory processes at aphasias. Vestnik Rossiiskoi Akademii Meditsinskikh Nauk 12: 28-32
Popova, I.Y.; Vinogradova, O.S.; Kokoz, Y.M.; Ziganshin, R.K.; Ivanov, V.T. 2003: Neuropeptide modulation of evoked responses of neurons in the medial septal region of hibernating ground squirrels in conditions of chronic isolation of the medial septal region from preoptic-hypothalamic structures. Neuroscience and Behavioral Physiology 33(5): 521-528
Chaki, S.; Okuyama, S. 2006: Neuropeptide receptors: novel therapeutic targets for depression. Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 127(3): 196-200
Larsen, G.L.; Fratelli, C.; Loader, J.; Kang, J.-K.B.; Dakhama, A. 2006: Neuropeptide release from airways of young and fully-grown rabbits. Pediatric Pulmonology 41(12): 1242-1249
Strecker, T.; Messlinger, K. 2003: Neuropeptide release in the dura mater encephali in response to nitric oxide--relevance for the development of vascular headaches?. Schmerz 17(3): 179-184
Vink, R.; Young, A.; Bennett, C.J.; Hu, X.; Connor, C.O.; Cernak, I.; Nimmo, A.J. 2003: Neuropeptide release influences brain edema formation after diffuse traumatic brain injury. Acta Neurochirurgica. Suppl 86: 257-260
Ashmarin, I.P.; Asanova, L.M.; Abbasova, K.R.; Chepurnova, N.E.; Kossova, G.V.; Chepurnov, S.A.; Iniushkin, A.N.; Goncharov, O.B. 2003: Neuropeptide thyroliberin in ultra low doses--anticonvulsant defense of the brain. Radiatsionnaia Biologiia Radioecologiia 43(3): 324-327
Brumovsky, P.; Shi, T.S.; Landry, M.; Villar, M.J.; Hökfelt, T. 2007: Neuropeptide tyrosine and pain. Trends in Pharmacological Sciences 28(2): 93-102
Carvajal, C.; Dumont, Y.; Quirion, R. 2006: Neuropeptide y: role in emotion and alcohol dependence. Cns and Neurological Disorders Drug Targets 5(2): 181-195
Spinazzi, R.; Andreis, P.G.; Nussdorfer, G.G. 2005: Neuropeptide-Y and Y-receptors in the autocrine-paracrine regulation of adrenal gland under physiological and pathophysiological conditions (Review). International Journal of Molecular Medicine 15(1): 3-13
Clark, C.J.; Phillips, R.S.; Stone, T.W. 2003: Neuropeptide-containing cells in the cortex and striatum of mice with cerebral malaria. Advances in Experimental Medicine and Biology 527: 347-352
Kowiański, P.ła.; Moryś, J.M.; Wójcik, S.ła.; Dziewiatkowski, J.; Luczyńska, A.; Spodnik, E.; Timmermans, J.-P.; Moryś, J. 2004: Neuropeptide-containing neurons in the endopiriform region of the rat: morphology and colocalization with calcium-binding proteins and nitric oxide synthase. Brain Research 996(1): 97-110
Fricker, L.D. 2005: Neuropeptide-processing enzymes: applications for drug discovery. Aaps Journal 7(2): E449-E455
Yaraee, R.; Ebtekar, M.; Ahmadiani, A.; Sabahi, F. 2003: Neuropeptides (sp and CGRP) augment IL-1 Beta production in hsv-infected macrophages. Iranian Journal of Allergy Asthma and Immunology 2(2): 95-100
Lundy, F..T..; Linden, G..J.. 2004: Neuropeptides and Neurogenic Mechanisms in Oral and Periodontal Inflammation. Critical Reviews in Oral Biology and Medicine: An Official Publication of the American Association of Oral Biologists 15(2): 82-98
Roesler, R.; Henriques, Jão.Antônio.Pêgas.; Schwartsmann, G. 2004: Neuropeptides and anxiety disorders: bombesin receptors as novel therapeutic targets. Trends in pharmacological sciences 25(5): 241-2; author reply 242-3
Casini, G. 2005: Neuropeptides and retinal development. Archives Italiennes de Biologie 143(3-4): 191-198
Hatzinger, M. 2000: Neuropeptides and the hypothalamic-pituitary-adrenocortical (HPA) system: review of recent research strategies in depression. World Journal of Biological Psychiatry: the Official Journal of the World Federation of Societies of Biological Psychiatry 1(2): 105-111
Nishino, S.; Fujiki, N. 2007: Neuropeptides as possible targets in sleep disorders. Expert Opinion on Therapeutic Targets 11(1): 37-59
Fujiki, N.; Nishino, S. 2007: Neuropeptides as possible targets in sleep disorders: special emphasis on hypocretin-deficient narcolepsy. Cns and Neurological Disorders Drug Targets 6(1): 45-62
Landgraf, R. 2005: Neuropeptides in anxiety modulation. Handbook of Experimental Pharmacology 169: 335-369
Jimerson, D.C.; Wolfe, B.E. 2004: Neuropeptides in eating disorders. Cns Spectrums 9(7): 516-522
Swaab, D.F. 2004: Neuropeptides in hypothalamic neuronal disorders. International Review of Cytology 240: 305-375
Szczepańska-Sadowska, E. 2006: Neuropeptides in neurogenic disorders of the cardiovascular control. Journal of Physiology and Pharmacology: An Official Journal of the Polish Physiological Society 57(Suppl 11): 31-53
Predel, R.; Herbert, Zófia.; Eckert, M. 2003: Neuropeptides in perisympathetic organs of Manduca sexta: specific composition and changes during the development. Peptides 24(10): 1457-1464
Belzung, C.; Yalcin, I.; Griebel, G.; Surget, A.; Leman, S. 2006: Neuropeptides in psychiatric diseases: an overview with a particular focus on depression and anxiety disorders. Cns and Neurological Disorders Drug Targets 5(2): 135-145
de Bree, F. 2001: Neuropeptides in the therapy of Alzheimer's disease. Drug News and Perspectives 14(3): 151-157
De Wied, D.; Sigling, H.O.. 2002: Neuropeptides involved in the pathophysiology of schizophrenia and major depression. Neurotoxicity Research 4(5-6): 453-468
Ramírez, M.; Prieto, I.; Vives, F.; de Gasparo, M.; Alba, F. 2004: Neuropeptides, neuropeptidases and brain asymmetry. Current Protein and Peptide Science 5(6): 497-506
Hökfelt, T.; Bartfai, T.; Bloom, F. 2003: Neuropeptides: opportunities for drug discovery. Lancet. Neurology 2(8): 463-472
Svensson, M.; Sköld, K.; Nilsson, A.; Fälth, M.; Nydahl, K.; Svenningsson, P.; Andrén, P.E. 2007: Neuropeptidomics: MS applied to the discovery of novel peptides from the brain. Analytical Chemistry 79(1): 15-6 18-21
Chiu, H.-C. 2004: Neuropharmacoeconomics. Acta Neurologica Taiwanica 13(2): 87-96
Nguyen, H.O.X.; Goracke-Postle, C.J.; Kaminski, L.L.; Overland, A.C.; Morgan, A.D.; Fairbanks, C.A. 2003: Neuropharmacokinetic and dynamic studies of agmatine (decarboxylated arginine). Annals of the new York Academy of Sciences 1009: 82-105
Ferguson, J.T. 1957: Neuropharmacological agents in rehabilitation of patients with chronic mental illness; a three-year clinical evaluation. Journal of the American Medical Association 165(13): 1677-1682
Stern, P. 1960: Neuropharmacological analyses with rats. Arzneimittel-Forschung 10: 113-116
Killam, K.F. 1960: Neuropharmacological approaches to the study of drug action. Stanford Medical Bulletin 18: 21-24
Zaleski, M.; Morato, G.S.; Silva, V.A.d.; Lemos, T. 2004: Neuropharmacological aspects of chronic alcohol use and withdrawal syndrome. Revista Brasileira de Psiquiatria 26(Suppl 1): S40-S42
Mula, M.; Trimble, M.R. 2006: Neuropharmacological aspects of cognitive neurorehabilitation in epilepsy. Behavioural Neurology 17(1): 69-75
Tomić, M.; Tovilović, G.; Butorović, B.; Krstić, D.; Janković, T.; Aljancić, I.; Menković, N. 2005: Neuropharmacological evaluation of diethylether extract and xanthones of Gentiana kochiana. Pharmacology Biochemistry and Behavior 81(3): 535-542
Hayward, P. 2003: Neuropharmacological key to cortical plasticity found. LANCET. Neurology 2(8): 456
Chamberlain, S.R.; Müller, U.; Robbins, T.W.; Sahakian, B.J. 2006: Neuropharmacological modulation of cognition. Current Opinion in Neurology 19(6): 607-612
Parton, A.; Coulthard, E.; Husain, M. 2005: Neuropharmacological modulation of cognitive deficits after brain damage. Current Opinion in Neurology 18(6): 675-680
Pérez Saad, H.; Buznego, M.T.; Llanio Villate, M.; Fernández Perez, M.; Menéndez, R. 2003: Neuropharmacological profile of Plectranthus amboinicus (Lour.) Spreng. (Indian borage). Revista de Neurologia 36(1): 98-99
Yui, T.; Takeo, Y. 1958: Neuropharmacological studies on a new series of ergot alkaloids; elymoclavine as a potent analeptic on reserpine-sedation. Japanese Journal of Pharmacology 7(2): 157-161
Yui, T.; Takeo, Y. 1958: Neuropharmacological studies on a new series of ergot alkaloids; the effects on electrocorticogram of rabbits. Japanese Journal of Pharmacology 7(2): 162-168
Matthews, R.J.; Roberts, B.J.; Adkins, P.K. 1961: Neuropharmacological studies on dl-alpha-ethyltryptamine acetate. Journal of Neuropsychiatry 2(Suppl 1): 151-158
Schneider, J.A.; Sigg, E.B. 1957: Neuropharmacological studies on ibogaine, an indole alkaloid with central-stimulant properties. Annals of the new York Academy of Sciences 66(3): 765-776
Schumacher, H.; Classen, H.G. 1962: Neuropharmacological studies on the analysis of pupillar motor activity. Albrecht Von Graefe's Archiv für Ophthalmologie 164: 533-537
Sánchez-Mateo, C.C.; Darias, V.; Expósito-Orta, M.A.; Albertos, L.M. 2003: Neuropharmacological study of hetero[2,1]benzothiazepine derivatives analogues of tianeptine. Farmaco 58(1): 1-10
Kudrin, V.S.; Klodt, P.M.; Gulieva, S.T. 2005: Neuropharmacological study of the joint action of verapamil and olanzapine on the content of neurotransmitters in Wistar rat brain structures. Eksperimental'naia i Klinicheskaia Farmakologiia 68(6): 12-14
Lechin, F.; van der Dijs, B. 2005: Neuropharmacological therapy of carcinoid syndrome. Neuroendocrinology 81(3): 137-138
Lechin, F.; van der Dijs, B.; Orozco, B.; Rodriguez, S.; Baez, S. 2005: Neuropharmacological therapy of polycythemia vera: roles of circulating catecholamines and serotonin. Thrombosis and Haemostasis 93(1): 175-177
McNamara, P.; Durso, R. 2006: Neuropharmacological treatment of mental dysfunction in Parkinson's disease. Behavioural Neurology 17(1): 43-51
Youdim, M.B.H.; Maruyama, W.; Naoi, M. 2005: Neuropharmacological, neuroprotective and amyloid precursor processing properties of selective MAO-B inhibitor antiparkinsonian drug, rasagiline. Drugs of Today 41(6): 369-391
Sigg, E.B.; Gyermek, L.; Hill, R.T.; Yen, H.C. 1964: Neuropharmacology of some Hormone Derivatives. Archives Internationales de Pharmacodynamie et de Therapie 149: 164-180
Szabadi, E. 2002: Neuropharmacology and behavioral pharmacology. Idrugs: the Investigational Drugs Journal 5(8): 737-740
Skingsley, D.; Bradley, E.J.; Nolan, P. 2006: Neuropharmacology and mental health nurse prescribers. Journal of Clinical Nursing 15(8): 989-997
Woodbury, D.M.; Esplin, D.W. 1959: Neuropharmacology and neurochemistry of anticonvulsant drugs. Research Publications - Association for Research in Nervous and Mental Disease 37: 24-56
Fagerström, K.; Balfour, D.J.K. 2006: Neuropharmacology and potential efficacy of new treatments for tobacco dependence. Expert Opinion on Investigational Drugs 15(2): 107-116
Pollard, I. 2007: Neuropharmacology of drugs and alcohol in mother and fetus. Seminars in Fetal and Neonatal Medicine 12(2): 106-113
Nemeroff, C.B.; Owens, M.J. 2003: Neuropharmacology of paroxetine. Psychopharmacology Bulletin 37 Suppl. 1: 8-18
Peterson, C.G. 1955: Neuropharmacology of procaine. I. Peripheral nervous actions. Anesthesiology 16(5): 678-698
Peterson, C.G. 1955: Neuropharmacology of procaine. II. Central nervous actions. Anesthesiology 16(6): 976-993
Tedeschi, R.E.; Tedeschi, D.H.; Fellows, E.J. 1962: Neuropharmacology of tranylcypromine and trifluoperazine. Canadian Psychiatric Association Journal 7(Suppl): 55-59
Jung, R. 1958: Neuropharmacology; central mechanisms of action of chemical substances and their neurophysiological principles. Klinische Wochenschrift 36(24): 1153-1167
Frecska, E.; Csökli, Z.; Nagy, A.; Kulcsár, Z. 2004: Neurophenomenological analysis of the therapeutic relationship in ritual healing. Neuropsychopharmacologia Hungarica: a Magyar Pszichofarmakologiai Egyesulet Lapja 6(3): 133-143
Doll, E.A. 1951: Neurophrenia. American Journal of Psychiatry 108(1): 50-53
Pereyra Kafer, J.; Poch, G.F.; Figini, H.A.; Biquard, C. 1960: Neurophthoencephalomyelitis of hemiparetic form. La Semana Medica 117: 153-154
Salm, K. 1965: Neurophychiatry in a Central Hospital. Suomen Laakarilehti. Finlands Lakartidning 20: 684-686
Imbriano, A.E. 1952: Neurophypophyseal and intrarenal osmoregulation of diuresis. La Semana Medica 100(21): 661-663
Palestini, M.; Davidovich, A.; Armengol, V. 1963: Neurophysiologic Aspects of Sleep and Habituation. Acta Physiologica Latino Americana 13: 67-70
Bertharion, G.; Beyssat, J. 1965: Neurophysiologic Mechanism of Prevention of Hyperoxic Convulsions in the Rat by Means of Manganese Sulfate. Journal de Physiologie 57: 226-227
Kawasaki, M.; Ogura, J.H.; Takenouchi, S. 1964: Neurophysiologic Observations of Normal Deglutition. I. its Relationship to the Respiratory Cycle. Laryngoscope 74: 1747-1765
Kawasaki, M.; Ogura, J.H.; Takenouchi, S. 1964: Neurophysiologic Observations of Normal Deglutition. Ii. its Relationship to Allied Phenomena. Laryngoscope 74: 1766-1780
Schaefer, K.P.; Wieser, S. 1964: Neurophysiologic Studies on Essential Myoclonus. Archiv für Psychiatrie und Nervenkrankheiten 205: 571-590
Lehmann, H.E. 1956: Neurophysiologic activity of chlorpromazine in clinical use. Journal of Clinical and Experimental Psychopathology 17(2): 129-141
Spence, V.A. 2003: Neurophysiologic analysis of neuromuscular symptoms in UK Gulf War veterans. Neurology 61(12): 1827; Author Reply 1827
Eitner, S.; Wichmann, M.; Schultze-Mosgau, S.; Schlegel, A.; Leher, A.; Heckmann, J.; Heckmann, S.; Holst, S. 2006: Neurophysiologic and long-term effects of clinical hypnosis in oral and maxillofacial treatment--a comparative interdisciplinary clinical study. International Journal of Clinical and Experimental Hypnosis 54(4): 457-479
Masserman, J.H.; Pechtel, C. 1956: Neurophysiologic and pharmacologic influences on experimental neuroses. American Journal of Psychiatry 113(6): 510-514
Igic, R.; Alexander, B. 2006: Neurophysiologic approach to pruritus and pain in cancer patients. Journal of BUON: Official Journal of the Balkan Union of Oncology 11(2): 143-152
Hobson, A.R.; Furlong, P.L.; Sarkar, S.; Matthews, P.J.M.; Willert, R.P.; Worthen, S.F.; Unsworth, B.J.; Aziz, Q. 2006: Neurophysiologic assessment of esophageal sensory processing in noncardiac chest pain. Gastroenterology 130(1): 80-88
Hoff, H.; Pateisky, K. 1953: Neurophysiologic bases of the problems of parietal lobe function. Wiener Klinische Wochenschrift 65(36-37): 743-745
Olejniczak, P. 2006: Neurophysiologic basis of EEG. Journal of Clinical Neurophysiology: Official Publication of the American Electroencephalographic Society 23(3): 186-189
El-Husseini, A.A.; Abu-Hegazy, M.; El-Tantawi, A.E.-H.; Sobh, M.A.; Ghoneim, M.A. 2005: Neurophysiologic changes in live related kidney transplant children and adolescents. Pediatric Transplantation 9(5): 579-583
Slawecki, C.J.; Thomas, J.D.; Riley, E.P.; Ehlers, C.L. 2004: Neurophysiologic consequences of neonatal ethanol exposure in the rat. Alcohol 34(2-3): 187-196
Halford, J.J. 2003: Neurophysiologic correlates of psychiatric disorders and potential applications in epilepsy. Epilepsy and Behavior: E&b 4(4): 375-385
Brondz, I.; Hamdani, E.H.; Døving, K. 2004: Neurophysiologic detector-a selective and sensitive tool in high-performance liquid chromatography. Journal of Chromatography. B Analytical Technologies in the Biomedical and Life Sciences 800(1-2): 41-47
Dodge, P.R.; Sotos, J.F.; Gamstorp, I.; Devivo, D.; Levy, M.; Rabe, T. 1962: Neurophysiologic disturbances in hypertonic dehydration. Transactions of the American Neurological Association 87: 33-36
Jouvet, M.; Schott, B.; Courjon, J.; Allegre, G. 1959: Neurophysiologic documents relative to the mechanisms of attention in man. Revue Neurologique (Paris) 100: 437-450
Crouzier, D.; Debouzy, J.C.; Bourbon, F.; Collin, A.; Perrin, A.; Testylier, G. 2007: Neurophysiologic effects at low level 1.8 GHz radiofrequency field exposure: a multiparametric approach on freely moving rats. Pathologie-Biologie 55(3-4): 134-142
Aird, R.B.; Strait, L.A.; Pace, J.W.; Hrenoff, M.K.; Bowditch, S.C. 1956: Neurophysiologic effects of electrically induced convulsions. A.M.A. Archives of Neurology and Psychiatry 75(4): 371-378
DeRegnier, R.-A. 2005: Neurophysiologic evaluation of early cognitive development in high-risk infants and toddlers. Mental Retardation and Developmental Disabilities Research Reviews 11(4): 317-324
Yablon, S.A.; Stokic, D.S. 2004: Neurophysiologic evaluation of spastic hypertonia: implications for management of the patient with the intrathecal baclofen pump. American Journal of Physical Medicine and Rehabilitation 83(10 Suppl): S10-S18
Desmeules, J.A.; Cedraschi, C.; Rapiti, E.; Baumgartner, E.; Finckh, A.; Cohen, P.; Dayer, P.; Vischer, T.L. 2003: Neurophysiologic evidence for a central sensitization in patients with fibromyalgia. Arthritis and Rheumatism 48(5): 1420-1429
Yalnizoğlu, D.; Sari, N.; Turanli, G.üz.; Coşkun, T.; Topçu, M. 2005: Neurophysiologic features in glutaric aciduria type i. Turkish Journal of Pediatrics 47(2): 153-158
Schipper, J.; Ridder, G.J.; Arapakis, I.; Gellrich, N.-C.; Spetzger, U.; Maier, W. 2004: Neurophysiologic intraoperative monitoring to preserve cranial nerve function in base of skull surgery. Hno 52(10): 897-907
Crommelinck, M. 2003: Neurophysiologic mechanisms of face recognition. Bulletin et Memoires de l'Academie Royale de Medecine de Belgique 158(3-4): 177-189; Discussion: 189-191
Fowler, C.J. 2000: Neurophysiologic pelvic floor testing. Supplements to Clinical Neurophysiology 53: 231-233
Husain, A.M. 2006: Neurophysiologic studies in Krabbe disease. Supplements to Clinical Neurophysiology 59: 289-298
Josephs, K.A.; Silber, M.H.; Fealey, R.D.; Nippoldt, T.B.; Auger, R.G.; Vernino, S. 2004: Neurophysiologic studies in Morvan syndrome. Journal of Clinical Neurophysiology: Official Publication of the American Electroencephalographic Society 21(6): 440-445
Schelhaas, H.J.; van de Warrenburg, B.P.C.; Bos, M.M.; Houtman, C.J.; Scheffer, H.; Gabreëls-Festen, A.; Kremer, B.; Zwarts, M.J. 2006: Neurophysiologic studies in early-onset cerebellar ataxia. Journal of Clinical Neurophysiology: Official Publication of the American Electroencephalographic Society 23(4): 381-387
Kułak, W.; Sobaniec, W.; Boćkowski, L.; Sołowiej, E.; Smigielska-Kuzia, J.; Artemowicz, B.; Sendrowski, K. 2005: Neurophysiologic studies of brain plasticity in children with cerebral palsy. Roczniki Akademii Medycznej W Bialymstoku 50(Suppl 1): 74-77
Strata, P. 1964: Neurophysiological analysis of the "Mobbing Response" in the chaffinch (Fringilla Coelebs). Archives Italiennes de Biologie 102: 22-28
Vizioli, R. 1964: Neurophysiological Bases of Catalepsy. Electroencephalography and Clinical Neurophysiology 16: 191-193
Jouvet, M. 1964: Neurophysiological Clinical Study of Disorders of Consciousness. Acta Neurochirurgica 12: 258-269
Deutsch, J.A. 1964: Neurophysiological Contrast Phenomena and Figural Aftereffects. Psychological Review 71: 19-26
Renaud, J. 1965: Neurophysiological Introduction to Aggressology. 3. Organization of Motor Command. Agressologie: Revue Internationale de Physio-Biologie et de Pharmacologie Appliquees Aux Effets de l'Agression 6: Suppl Xxxvi: 3+
Akert, K. 1964: Neurophysiological Observations on the Problem of the Topography of Skin Diseases. Archiv für Klinische und Experimentelle Dermatologie 219: 54-63
Hunsperger, R.W. 1965: Neurophysiological Principles of Affective Behavior. Bulletin der Schweizerischen Akademie der Medizinischen Wissenschaften 21: 8-22
Grandpierre, R.; Angiboust, R. 1964: Neurophysiological Problems Posed by Astronaut Flight. Effects of Variations in the Gravitational Field. Actualites Neurophysiologiques 5: 247-262
Kreindler, A. 1963: Neurophysiological Research on the Intracerebral Repercussiveness of the Neuronal Lesion. Revue Neurologique (Paris) 108: 958-963
Obradoralcalde, S. 1963: Neurophysiological Study of Cerebral Comas. Anales de la Real Academia Nacional de Medicina 80: 409-420
Adachi, A. 1964: Neurophysiological Study on Taste Effectiveness of Seasoning. Nihon Seirigaku Zasshi. Journal of the Physiological Society of Japan 26: 347-355
Kellinghaus, C.; Wibbeke, B.; Evers, S.; Reichelt, D.; Pollmann, H.; Husstedt, I.W. 2006: Neurophysiological abnormalities in HIV-infected long term survivors. European Journal of Medical Research 11(6): 245-249
Valls-Solé, J. 2006: Neurophysiological aids to the diagnosis of progressive supranuclear palsy (PSP). Supplements to Clinical Neurophysiology 58: 249-256
Traugott, N.N.; Balonov, L.I. 1958: Neurophysiological analysis of certain conditions resulting from aminazine administration. Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 58(5): 585-591
Traugott, N.N.; Balonov, L.I. 1961: Neurophysiological analysis of certain depressive syndromes. Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 61: 91-98
Sival, D.A.; van Weerden, T.W.; den Dunnen, W.F.A.; Timmer, A.; Staal-Schreinemachers, A.L.; Sollie, K.M.; Hoving, E.W.; Sauer, P.J.J.; Brouwer, O.F. 2002: Neurophysiological analysis of leg movements in infants with spina bifida aperta in the early postnatal period. European Journal of Pediatric Surgery: Official Journal of Austrian Association of Pediatric Surgery . et Al 12(Suppl 1): S29-S30
Hiebel, G.; Bonvallet, M.; Huve, P.; Dell, P. 1954: Neurophysiological analysis of the central action of d-amphetamine (maxiton). La Semaine des Hopitaux: Organe Fonde Par l'Association d'Enseignement Medical des Hopitaux de Paris 30(30): 1880-1887
Bartual Pastor, J. 1962: Neurophysiological analysis of the central integrator system of orientation in space in man by registration of ocular reactions after periodic optokinetic and vestibular stimulation. Revista Espanola de Oto-Neuro-Oftalmologia y Neurocirugia 21: 490-505 Contd
Dancause, N. 2006: Neurophysiological and anatomical plasticity in the adult sensorimotor cortex. Reviews in the Neurosciences 17(6): 561-580
Lewis, G.N.; Byblow, W.D. 2004: Neurophysiological and behavioural adaptations to a bilateral training intervention in individuals following stroke. Clinical Rehabilitation 18(1): 48-59
Oppliger, F.Y..; M Guerin, P.; Vlimant, M. 2000: Neurophysiological and behavioural evidence for an olfactory function for the dorsal organ and a gustatory one for the terminal organ in Drosophila melanogaster larvae. Journal of Insect Physiology 46(2): 135-144
Wollemann, M.; Katona, F. 1960: Neurophysiological and biochemical relations in ganglion-blocking. Minerva Anestesiologica 26: 497
Martić, V.; Perić, P. 2004: Neurophysiological and clinical aspect of patients with carpal tunnel syndrome. Acta Chirurgica Iugoslavica 51(4): 87-91
Taguchi, K.; Ren, J.; Utsunomiya, I.; Aoyagi, H.; Fujita, N.; Ariga, T.; Miyatake, T.; Yoshino, H. 2004: Neurophysiological and immunohistochemical studies on Guillain-Barre syndrome with IgG anti-GalNAc-GD1a antibodies-effects on neuromuscular transmission. Journal of the Neurological Sciences 225(1-2): 91-98
Happe, S.; Paulus, W. 2006: Neurophysiological and neuroimaging studies for restless legs syndrome and periodic leg movement disorder. Der Nervenarzt 77(6): 652; 654
Garcia, J.A. 1956: Neurophysiological and psychological considerations of painless labor. Revista de Ginecologia E d'Obstetricia 50(6): 473-486
Viel, E.J. 2005: Neurophysiological approach in the peripheral anesthetic blocks as a diagnosis and prognosis tool for spasticity. Clinical Neurophysiology: Official Journal of the International Federation of Clinical Neurophysiology 116(7): 1491-1492
Rossi, P.; Serrao, M.; Perrotta, A.; Pierelli, F.; Sandrini, G.; Nappi, G. 2005: Neurophysiological approach to central pain modulation in primary headaches. Journal of Headache and Pain 6(4): 191-194
Plas, R.; Barrabino, J.H.; Naquet, R. 1960: Neurophysiological approach to the problem of the specificity of therapeutic action of tranquilizing drugs. I. Acute experimentation. Revue Neurologique (Paris) 103: 263-264
Pampiglione, G. 1960: Neurophysiological aspects of cerebral ischaemia. Proceedings of the Royal Society of Medicine 53: 329-332
Buettner, U.W. 2005: Neurophysiological aspects of chronic pain. Praxis 94(50): 2003-2005
Van Wulfften Palthe, P.M. 1954: Neurophysiological aspects of fatigue. Aeromedica Acta 3: 25-39
Walsh, J.P. 1951: Neurophysiological aspects of mastication. Dental Journal of Australia 23(2): 49-62
Cortoos, A.; Verstraeten, E.; Cluydts, R. 2006: Neurophysiological aspects of primary insomnia: implications for its treatment. Sleep Medicine Reviews 10(4): 255-266
Wikler, A. 1953: Neurophysiological aspects of the opiate and barbiturate abstinence syndromes. Research Publications - Association for Research in Nervous and Mental Disease 32: 269-286
Jouvet, M. 1956: Neurophysiological aspects of various behavior mechanisms. Journal de Psychologie Normale et Pathologique 53(2): 141-162
Galeotti, F.; Truini, A.; Cruccu, G. 2006: Neurophysiological assessment of craniofacial pain. Journal of Headache and Pain 7(2): 61-69
Perényi, János.; Fazekas, Aás.; Benedek, Görgy. 2005: Neurophysiological background of pain in the orofacial area: review of the literature. Fogorvosi Szemle 98(5): 185-192
Fazio, C.; Soriani, S. 1962: Neurophysiological bases of modern technics of motor retraining in diseases of the central nervous system. Sistema Nervoso 14: 149-162
Bobath, C.K. 1958: Neurophysiological bases of our method of treatment of cerebral palsy. Acta Neurologica et Psychiatrica Belgica 58(6): 469-474
Rigaudière, F.; Leid, J.; Viénot, F.; Le Gargasson, J-F. 2006: Neurophysiological basis and clinical tests for assessment of X-linked color vision deficiencies in school children. Journal Francais d'Ophtalmologie 29(1): 87-102
Grusser, O.J.; Creutzfeldt, O. 1957: Neurophysiological basis of Brücke-Bartley effect; maxima of impulse frequency of retinal and cortical neurons in flickering light of middle frequency. Pflugers Archiv für die Gesamte Physiologie des Menschen und der Tiere 263(6): 668-681
Velayudhan, M.K. 2004: Neurophysiological basis of learning from error observation. National Medical Journal of India 17(5): 257-258
El-Salem, K.; Ammari, F. 2006: Neurophysiological changes in neurologically asymptomatic hypothyroid patients: a prospective cohort study. Journal of Clinical Neurophysiology: Official Publication of the American Electroencephalographic Society 23(6): 568-572
Wang, D.-y.; Bu, X.-k.; Xing, G.-q.; Lu, L. 2003: Neurophysiological characteristics of infants and young children with auditory neuropathy. Zhonghua Yi Xue Za Zhi 83(4): 281-284
Lisanby, S.H.; Moscrip, T.; Morales, O.; Luber, B.; Schroeder, C.; Sackeim, H.A. 2003: Neurophysiological characterization of magnetic seizure therapy (MST) in non-human primates. Supplements to Clinical Neurophysiology 56: 81-99
Tikhonova, I.V.; Gnezditskii, V.V.; Stakhovskaya, L.V.; Skvortsova, V.I. 2003: Neurophysiological characterization of transitory global amnesia syndrome. Neuroscience and Behavioral Physiology 33(2): 171-175
Shibasaki, H. 2006: Neurophysiological classification of myoclonus. Neurophysiologie Clinique 36(5-6): 267-269
Mysak, E.D.; Fiorentino, M.R. 1961: Neurophysiological considerations in occupational therapy for the cerebral palsied. American Journal of Occupational Therapy: Official Publication of the American Occupational Therapy Association 15: 112-117
Lewis, M.D.; Lamm, C.; Segalowitz, S.J.; Stieben, J.; Zelazo, P.D. 2006: Neurophysiological correlates of emotion regulation in children and adolescents. Journal of Cognitive Neuroscience 18(3): 430-443
Veltman, D.J.; de Ruiter, M.B.; Rombouts, S.A.R.B.; Lazeron, R.H.C.; Barkhof, F.; Van Dyck, R.; Dolan, R.J.; Phaf, R.H. 2005: Neurophysiological correlates of increased verbal working memory in high-dissociative participants: a functional MRi study. Psychological Medicine 35(2): 175-185
Aftanas, L.I.; Reva, N.V.; Savotina, L.N.; Makhnev, V.P. 2004: Neurophysiological correlates of induced discrete emotions in humans: an individual analysis. Rossiiskii Fiziologicheskii Zhurnal Imeni I.M. Sechenova 90(12): 1457-1471
Aftanas, L.I.; Reva, N.V.; Savotina, L.N.; Makhnev, V.P. 2006: Neurophysiological correlates of induced discrete emotions in humans: an individually oriented analysis. Neuroscience and Behavioral Physiology 36(2): 119-130
Kobylarz, E.J.; Schiff, N.D. 2005: Neurophysiological correlates of persistent vegetative and minimally conscious states. Neuropsychological Rehabilitation 15(3-4): 323-332
Evarts, E.V. 1958: Neurophysiological correlates of pharmacologically-induced behavioral disturbances. Research Publications - Association for Research in Nervous and Mental Disease 36: 347-380
Sherwood, S.L. 1958: Neurophysiological data related to behavioural disorders. Confinia Neurologica 18(2-4): 315-317
Lauria, G.; Pareyson, D.; Sghirlanzoni, A. 2003: Neurophysiological diagnosis of acquired sensory ganglionopathies. European Neurology 50(3): 146-152
Abbruzzese, G.; Berardelli, A. 2006: Neurophysiological effects of botulinum toxin type a. Neurotoxicity Research 9(2-3): 109-114
Anyanwu, E.C.; Campbell, A.W.; Vojdani, A. 2003: Neurophysiological effects of chronic indoor environmental toxic mold exposure on children. Thescientificworldjournal 3: 281-290
Mokrushin, A.A.; Shalyapina, V.G. 2004: Neurophysiological effects of corticotropin-releasing factor in living slices of the olfactory area of the rat cortex. Neuroscience and Behavioral Physiology 34(1): 1-4
Pickar, J.G. 2002: Neurophysiological effects of spinal manipulation. Spine Journal: Official Journal of the North American Spine Society 2(5): 357-371
Suzuki, I. 2006: Neurophysiological evaluation of interictal cortical excitability in migraine. No to Shinkei 58(1): 17-27
Ständer, S.; Evers, S.; Metze, D.; Schmelz, M. 2005: Neurophysiological evidence for altered sensory function caused by storage of hydroxyethyl starch in cutaneous nerve fibres. British Journal of Dermatology 152(5): 1085-1086
McNeely, H.E.; West, R.; Christensen, B.K.; Alain, C. 2003: Neurophysiological evidence for disturbances of conflict processing in patients with schizophrenia. Journal of Abnormal Psychology 112(4): 679-688
Lu, M.; Kang, D.; Fan, D. 2006: Neurophysiological findings in a case of cervical anterior spinal artery syndrome: compound muscle action potentials, a marker for prognosis. New Zealand Medical Journal 119(1234): U1982
Schwartz, D.M.; Sestokas, A.K.; Hilibrand, A.S.; Vaccaro, A.R.; Bose, B.; Li, M.; Albert, T.J. 2006: Neurophysiological identification of position-induced neurologic injury during anterior cervical spine surgery. Journal of Clinical Monitoring and Computing 20(6): 437-444
Shafer, V.L.; Morr, M.L.; Datta, H.; Kurtzberg, D.; Schwartz, R.G. 2005: Neurophysiological indexes of speech processing deficits in children with specific language impairment. Journal of Cognitive Neuroscience 17(7): 1168-1180
Jouvet, M.; Michel, F. 1961: Neurophysiological interpration of the EEG aspects of sleep as a function of the existence of 2 different inhiditory systems. Revue Neurologique (Paris) 102: 310-311
Gastaut, H.; Naquet, R.; Roger, A.; Dongier, S.; Regis, H.; Marrell, F.; Jus, A.; Jus, C. 1957: Neurophysiological interpretation of conditioned electroencephalographic reactions. Zhurnal Vysshei Nervnoi Deiatelnosti Imeni i P Pavlova 7(2): 203-213
Pierzchała, K.; Łabuz-Roszak, B.; Ograbek, M.; Tazbirek, M. 2002: Neurophysiological investigations in patients with sleep apnoea syndrome. Wiadomosci Lekarskie 55(11-12): 685-690
Ferreri, F.; Rossini, P.M. 2004: Neurophysiological investigations in restless legs syndrome and other disorders of movement during sleep. Sleep Medicine 5(4): 397-399
Péréon, Y. 2004: Neurophysiological investigations of respiratory function. Revue Medicale de Liege 59(Suppl 1): 150-156
Lion, K.S. 1952: Neurophysiological investigations the scope and limitations of electronic amplifiers. British Journal of Physical Medicine: Including its Application to Industry 15(4): 90-93
Kaeser, H.E. 1962: Neurophysiological knowledge on the problem of neuritis. Bulletin der Schweizerischen Akademie der Medizinischen Wissenschaften 18: 196-215
Schmah, M.; Horn, E. 2005: Neurophysiological long-term recordings in space: experiments Scorpi and Scorpi-T. Gravitational and Space Biology Bulletin: Publication of the American Society for Gravitational and Space Biology 18(2): 95-96
Kang, K.; Williams, L.M.; Hermens, D.; Gordon, E. 2005: Neurophysiological markers of contextual processing: the relationship between P3b and Gamma synchrony and their modulation by arousal, performance and individual differences. Brain Research. Cognitive Brain Research 25(2): 472-483
Friederici, A.D. 2005: Neurophysiological markers of early language acquisition: from syllables to sentences. Trends in Cognitive Sciences 9(10): 481-488
de Carvalho, M.; Chio, A.; Dengler, R.; Hecht, M.; Weber, M.; Swash, M. 2005: Neurophysiological measures in amyotrophic lateral sclerosis: markers of progression in clinical trials. Amyotrophic Lateral Sclerosis and other Motor Neuron Disorders: Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases 6(1): 17-28
Pollock, G.H. 1952: Neurophysiological mechanisms in electroconvulsive shocks. American Journal of Psychiatry 109(2): 143-144
Pieron, H. 1962: Neurophysiological mechanisms of critical flicker frequence and harmonic phenomena. Journal of the Optical Society of America 52: 475
Hardy, J. 1961: Neurophysiological mechanisms of parkinsonian tremor. L'Union Medicale du Canada 90: 131-147
Machinskaia, R.I. 2003: Neurophysiological mechanisms of voluntary attention: a review. Zhurnal Vysshei Nervnoi Deiatelnosti Imeni i P Pavlova 53(2): 133-150
Voerman, G.E.; Gregoric, M.; Hermens, H.J. 2005: Neurophysiological methods for the assessment of spasticity: the Hoffmann reflex, the tendon reflex, and the stretch reflex. Disability and Rehabilitation 27(1-2): 33-68
Weigang, E.; Hartert, M.; Siegenthaler, M.P.; Pitzer-Hartert, K.; Luehr, M.; Sircar, R.; von Samson, P.; Beyersdorf, F. 2006: Neurophysiological monitoring during thoracoabdominal aortic endovascular stent graft implantation. European Journal of Cardio-Thoracic Surgery: Official Journal of the European Association for Cardio-Thoracic Surgery 29(3): 392-396
De Blas-Beorlegui, G.; Regidor-Bailly-Bailliere, I.; Fernández-Lorente, J.; León-Alonso-Cortés, J.; Montilla-Izquierdo, S.; Burgos, J. 2004: Neurophysiological monitoring in spine surgery. Spinal cord stimulation. Revista de Neurologia 38(1): 68-75
Liu, A.Y.; Lopez, J.R.; Do, H.M.; Steinberg, G.K.; Cockroft, K.; Marks, M.P. 2003: Neurophysiological monitoring in the endovascular therapy of aneurysms. AJNR. American Journal of Neuroradiology 24(8): 1520-1527
Rupprecht, S.; Tangermann-Gerk, K.; Schultze-Mosgau, S.; Neukam, F.W.; Ellrich, J. 2005: Neurophysiological monitoring of alveolar nerve function during sensor-controlled Er:YAG laser corticotomy in rabbits. Lasers in Surgery and Medicine 36(3): 186-192
Deftereos, S.N.; Panagopoulos, G.; Gryllia, M.; Georgonikou, D.; Polyzoi, M.; Kechagias, E.; Aessopos, A.; Karageorgiou, C.E. 2006: Neurophysiological monitoring of brainstem function in a patient with Wallenberg syndrome, using Vestibular Evoked Myogenic Potentials. Neurology Neurophysiology and Neuroscience 2006: 3
Bose, B.; Sestokas, A.K.; Schwartz, D.M. 2004: Neurophysiological monitoring of spinal cord function during instrumented anterior cervical fusion. Spine Journal: Official Journal of the North American Spine Society 4(2): 202-207
Gundlapalli, S.; Anand, R.S.; Schwartz, D.M.; Wierzbowski, L.R.; Cohen, D.E.; Cook-Sather, S.D. 2006: Neurophysiological monitoring under anesthesia to position a child with extreme lumbar spine flexion for MRi and CT scan. Paediatric Anaesthesia 16(2): 195-199
Burger, R.; Bendszus, M.; Vince, G.H.; Solymosi, L.; Roosen, K. 2004: Neurophysiological monitoring, magnetic resonance imaging, and histological assays confirm the beneficial effects of moderate hypothermia after epidural focal mass lesion development in rodents. Neurosurgery 54(3): 701
Guérit, J-Michel. 2005: Neurophysiological patterns of vegetative and minimally conscious states. Neuropsychological Rehabilitation 15(3-4): 357-371
Maslov, N.B.; Bloshchinskiĭ, I.A.; Maksimenko, V.N. 2003: Neurophysiological picture and genesis of fatigue, chronic fatigue, and overfatigue in the human operator. Fiziologiia Cheloveka 29(5): 123-133
Bisinella, G.L.; Birch, R.; Smith, S.J.M. 2003: Neurophysiological prediction of outcome in obstetric lesions of the brachial plexus. Journal of Hand Surgery 28(2): 148-152
Moruzzi, G. 1952: Neurophysiological premises regarding the pathogenesis of the epileptic convulsive seizure. Archivio Internazionale di Studi Neurologici 1(4): 487-500
Missiuro, W. 1960: Neurophysiological principles in the rehabilitation of physically disabled persons. American Journal of Physical Medicine 39: 171-177
Creutzfeldt, O. 1958: Neurophysiological principles of electrical stimulation of the brain. Neurochirurgia 1(1): 38-73
Adams, A.E. 1961: Neurophysiological principles of optokinetic reaction. Albrecht Von Graefe's Archiv für Ophthalmologie 163: 348-357
Werner, G. 1958: Neurophysiological principles of the effect of tranquilizing agents. Klinische Wochenschrift 36(9): 404-408
Helm, J. 1955: Neurophysiological problems of the process of expression. Zeitschrift für Psychologie Mit Zeitschrift für Angewandte Psychologie 158(3-4): 232-255
Rood, M.S. 1954: Neurophysiological reactions as a basis for physical therapy. Physical Therapy Review 34(9): 444-449
Borisch, N.; Haussmann, P. 2003: Neurophysiological recovery after open carpal tunnel decompression: comparison of simple decompression and decompression with epineurotomy. Journal of Hand Surgery 28(5): 450-454
Soos, J.; Detrehazy, K. 1954: Neurophysiological relations of agonal changes of adrenal glands. Frankfurter Zeitschrift für Pathologie 65(4): 520-526
Ali, S.T.; Rakkah, N.I. 2007: Neurophysiological role of sildenafil citrate (Viagra) on seminal parameters in diabetic males with and without neuropathy. Pakistan Journal of Pharmaceutical Sciences 20(1): 36-42
Brem, S.; Lang-Dullenkopf, A.; Maurer, U.; Halder, P.; Bucher, K.; Brandeis, D. 2005: Neurophysiological signs of rapidly emerging visual expertise for symbol strings. Neuroreport 16(1): 45-48
Fang, P.-C.; Chen, Y.-J.; Tu, Y.-F. 2003: Neurophysiological studies in a case of Sjögren-Larsson syndrome. Acta Paediatrica Taiwanica 44(6): 356-359
Galietta, G.; Giuliani, G.; Loizzo, A.; Amat, A.G.; Fumagalli, E.; De Feo, V.; Quaranta, E.; Paladino, L.; Capasso, A. 2005: Neurophysiological studies of Heteropteris glabra Hok. & Arn. (Malpighiaceae) in DBA/2J mice. Journal of Ethnopharmacology 97(3): 415-419
González-Hidalgo, M. 2005: Neurophysiological studies of the neuromuscular junction. Revista de Neurologia 41(3): 163-176
Sawa, M. 1962: Neurophysiological studies on behavior. No to Shinkei 14: 557-559
Aird, R.B.; Strait, L.S.; Zealear, D.; Hrenoff, M. 1952: Neurophysiological studies on cerebral concussion. Journal of Neurosurgery 9(4): 331-347
Struppler, A.; Struppler, E. 1960: Neurophysiological studies on deafferentated muscle in man. Zeitschrift für Biologie 111: 438-448
Galambos, R. 1961: Neurophysiological studies on learning and motivation. Federation Proceedings 20: 603-608
Ganglberger, J.A.; Marko, A. 1953: Neurophysiological studies on sedative components of thyreostatic dimethylolmercaptobenzimidazole. Wiener Zeitschrift für Nervenheilkunde und Deren Grenzgebiete 8(1-2): 134-151
Schallek, W. 1960: Neurophysiological studies with monoamine oxidase inhibitors. Diseases of the Nervous System 21(3)suppl: 64-66
Lorenzoni, P.José.; Kay, Cáudia.Suely.Kamoi.; Arruda, W.Oleschko.; Scola, R.Herminia.; Werneck, L.César. 2006: Neurophysiological study in slow-channel congenital myasthenic syndrome: case report. Arquivos de Neuro-Psiquiatria 64(2a): 318-321
Balonov, L.A.; Sandomirskii, M.I.; Traugott, N.N.; Chistovich, A.S. 1950: Neurophysiological study of acute infectious psychoses. Nevropatologiia i Psikhiatriia 19(4): 65-70
Dechaume, J.; Jouvet, M.; Courjon, J.; Schott, B.; Allegre, G.; Vautrin, C. 1957: Neurophysiological study of attention in man; its subcortical mechanisms. Lyon Medical 89(45): 473-480
Openshaw, H.; Beamon, K.; Synold, T.W.; Longmate, J.; Slatkin, N.E.; Doroshow, J.H.; Forman, S.; Margolin, K.; Morgan, R.; Shibata, S.; Somlo, G. 2004: Neurophysiological study of peripheral neuropathy after high-dose Paclitaxel: lack of neuroprotective effect of amifostine. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 10(2): 461-467
Rzaeva, N.M. 2003: Neurophysiological study of short-latency potentials in central structures of visual system and their relations to additional oscillations in retina. Rossiiskii Fiziologicheskii Zhurnal Imeni I.M. Sechenova 89(5): 564-571
Jouvet, M.; Courjon, J. 1959: Neurophysiological study of the central action of methyl alpha-phenyl-2-piperidineacetate hydrochloride (ritalin). Archives Internationales de Pharmacodynamie et de Therapie 119(1-2): 189-193
Faure, J. 1958: Neurophysiological study of the effect of a vitamin B group on cerebral cortex, thalamus and rhinencephalon of active and free rabbit. Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales 152(2): 344-346
Plas, R.; Naquet, R. 1959: Neurophysiological study of the psychosedative Ro-4.0403. Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales 153: 1411-1415
Struppler, A. 1962: Neurophysiological study on pain. Is there a specific pain pathway?. Munchener Medizinische Wochenschrift 104: 2225-2236
De Renzi, E. 1957: Neurophysiological study on the effects of succinylcholine on the end-plate in man, with special reference to the phenomena of depression & facilitation. Rivista di Neurologia 27(2): 147-161
Kostera-Pruszczyk, A.; Rowińska-Marcińska, K.; Emeryk-Szajewska, B. 2003: Neurophysiological testing in myasthenia syndromes. Neurologia i Neurochirurgia Polska 37(1): 161-172
Pitt, M.; Pressler, R. 2005: Neurophysiological testing in the newborn and infant. Early Human Development 81(12): 939-946
Rowe, D.L.; Robinson, P.A.; Rennie, C.J.; Harris, A.W.; Felmingham, K.L.; Lazzaro, I.L.; Gordon, E. 2004: Neurophysiologically-based mean-field modelling of tonic cortical activity in post-traumatic stress disorder (PTSD), schizophrenia, first episode schizophrenia and attention deficit hyperactivity disorder (ADHD). Journal of Integrative Neuroscience 3(4): 453-487
Dyer, O. 2003: Neurophysiologist reprimanded by UK General Medical Council. Lancet. Neurology 2(6): 327
Neme, M. 1957: Neurophysiology and a broadened concept of industrial accidents. La Semana Medica 111(11): 524
Giurgea, C. 1964: Neurophysiology and Conditioning. Annales de la Societe Royale des Sciences Medicales et Naturelles de Bruxelles 17: 53-88
Gloor, P. 1963: Neurophysiology as the Basis of Clinical Neurology. Schweizerische Medizinische Wochenschrift 93: 1293-1300
Guillard, A. 1964: Neurophysiology of Sleep. Concours Medical 86: 2165-2175
Lebascle, J. 1955: Neurophysiology Week at la Salpétrière; 8-13 November 1954. Maroc Medical 34(357): 141-143
Fischer, E. 1958: Neurophysiology a physical therapist should know. Physical Therapy Review 38(11): 741-748
Van Wulfften Palthe, P.M. 1953: Neurophysiology and aviation medicine. Folia Psychiatrica Neurologica et Neurochirurgica Neerlandica 56(4): 557-565
Creutzfeldt, O.; Struck, G. 1962: Neurophysiology and morphology of the chronically isolated cortical islet in the cat: brain potentials and neuron activity of an isolated nerve cell population without afferent fibers. Archiv für Psychiatrie und Nervenkrankheiten Vereinigt Mit Zeitschrift für die Gesamte Neurologie und Psychiatrie 203: 708-731
Tramo, M.J.; Cariani, P.A.; Koh, C.K.; Makris, N.; Braida, L.D. 2005: Neurophysiology and neuroanatomy of pitch perception: auditory cortex. Annals of the new York Academy of Sciences 1060: 148-174
Ortega-Albás, J.J.; Serrano-García, A.L. 2003: Neurophysiology in Creutzfeldt-Jakob disease. Revista de Neurologia 36(4): 376-380
Segawa, M. 2003: Neurophysiology of Tourette's syndrome: pathophysiological considerations. Brain and Development 25(Suppl 1): S62-S69
Jäntti, V.; Yli-Hankala, A. 2000: Neurophysiology of anaesthesia. Supplements to Clinical Neurophysiology 53: 84-88
Leon-Sarmiento, F.E.; Bayona-Prieto, J.; Gomez, J. 2005: Neurophysiology of blepharospasm and multiple system atrophy: clues to its pathophysiology. Parkinsonism and Related Disorders 11(3): 199-201; Author Reply 203-4
Anken, R.H. 2003: Neurophysiology of developing fish at altered gravity: background--facts--perspectives. Advances in Space Biology and Medicine 9: 173-200
Olds, J. 1956: Neurophysiology of drive. Psychiatric Research Reports 6: 15-20
Yoshimura, N.; Chancellor, M.B. 2003: Neurophysiology of lower urinary tract function and dysfunction. Reviews in Urology 5(Suppl 8): S3
Fessard, A. 1952: Neurophysiology of motoricity; function and role of proprioceptors. L'Annee Psychologique 52(1): 101-113
Cassim, F.; Houdayer, E. 2006: Neurophysiology of myoclonus. Neurophysiologie Clinique 36(5-6): 281-291
Muller, A.; Sherman, R.; Weiss, J.; Addison, R.; Carr, D.; Harden, R.N. 2006: Neurophysiology of pain from landmine injury. Pain Medicine 7(Suppl 2): S204-S208
Tandon, O.P.; Malhotra, V.; Tandon, S.; D'Silva, I. 2003: Neurophysiology of pain: insight to orofacial pain. Indian Journal of Physiology and Pharmacology 47(3): 247-269
Merchant, H.; Georgopoulos, A.P. 2006: Neurophysiology of perceptual and motor aspects of interception. Journal of Neurophysiology 95(1): 1-13
Larsen, A. 2004: Neurophysiology of pleasure. Duodecim; Laaketieteellinen Aikakauskirja 120(23): 2783-2787
Gardner, E.P.; Babu, K.Srinivasa.; Reitzen, S.D.; Ghosh, S.; Brown, A.S.; Chen, J.; Hall, A.L.; Herzlinger, M.D.; Kohlenstein, J.B.; Ro, J.Y. 2007: Neurophysiology of prehension. I. Posterior parietal cortex and object-oriented hand behaviors. Journal of Neurophysiology 97(1): 387-406
Gardner, E.P.; Ro, J.Y.; Babu, K.S.; Ghosh, S. 2007: Neurophysiology of prehension. II. Response diversity in primary somatosensory (S-I) and motor (M-I) cortices. Journal of Neurophysiology 97(2): 1656-1670
Raap, U.; Ikoma, A.; Kapp, A. 2006: Neurophysiology of pruritus. Der Hautarzt; Zeitschrift für Dermatologie Venerologie und verwandte Gebiete 57(5): 379-380; 382-384
Ständer, S.; Steinhoff, M.; Schmelz, M.; Weisshaar, E.; Metze, D.; Luger, T. 2003: Neurophysiology of pruritus: cutaneous elicitation of itch. Archives of Dermatology 139(11): 1463-1470
Ikoma, A.; Rukwied, R.; Ständer, S.; Steinhoff, M.; Miyachi, Y.; Schmelz, M. 2003: Neurophysiology of pruritus: interaction of itch and pain. Archives of Dermatology 139(11): 1475-1478
Baumgartner, G.; Hakas, P. 1962: Neurophysiology of simultaneous brightness contrast. Reciprocal reactions of antagonistic groups of neurons of the visual system. Pflugers Archiv für die Gesamte Physiologie des Menschen und der Tiere 274: 489-510
Schubert, G. 1958: Neurophysiology of simultaneous contrast; present state of the relation between neurophysiology of the retina and optic perceptions. Albrecht Von Graefe's Archiv für Ophthalmologie 160(1): 94-97
Harris, C.D. 2005: Neurophysiology of sleep and wakefulness. Respiratory Care Clinics of North America 11(4): 567-586
Chancellor, M.B.; Yoshimura, N. 2004: Neurophysiology of stress urinary incontinence. Reviews in Urology 6(Suppl 3): S19-S28
Attarian, S. 2004: Neurophysiology of systemic diseases. Revue Medicale de Liege 59(Suppl 1): 108-111
García-García, A.; Calleja-Fernández, J. 2004: Neurophysiology of the development and maturation of the peripheral nervous system. Revista de Neurologia 38(1): 79-83
Motofei, I.G.; Rowland, D.L. 2005: Neurophysiology of the ejaculatory process: developing perspectives. Bju International 96(9): 1333-1338
Merchant, H.; Battaglia-Mayer, A.; Georgopoulos, A.P. 2004: Neurophysiology of the parieto-frontal system during target interception. Neurology and Clinical Neurophysiology: Ncn 2004: 1
Zealear, D.L.; Billante, C.R. 2004: Neurophysiology of vocal fold paralysis. Otolaryngologic Clinics of North America 37(1): 1-23 V
Langworthy, O.R. 1962: Neurophysiology, chemistry and endocrinology. American Journal of Psychiatry 118: 581-584
Langworthy, O.R. 1961: Neurophysiology, endocrinology and chemistry. American Journal of Psychiatry 117: 581-583
Andersen, P. 1965: Neurophysiology--Neuroanatomy. Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 85: 115-119
Von Muralt, A. 1954: Neurophysiology; old and new facts and theories. Lancet 266(6810): 473-475
Mattioli-Foggia, C.; Cossio, M. 1957: Neurophysiopathological aspects of catatonia. Rivista di Patologia Nervosa E Mentale 78(3): 867-874
Givre, A. 1958: Neurophysiopathological sequels of cranial wounds of boxers. El Dia Medico 30(81): 2863 Passim
De Castro, L.F. 1958: Neuropigmentary system & cell division in the maintenance of the vital equilibrium of tissue: new theory. Hospital 53(4): 553-557
Lagutenko, I.P. 2004: Neuropil internal apparatus coelomate: reconstruction of its early evolutionary steps. Zhurnal Evoliutsionnoi Biokhimii i Fiziologii 40(6): 546-555
De Winter, F.; Holtmaat, A.J.G.D.; Verhaagen, J. 2002: Neuropilin and class 3 semaphorins in nervous system regeneration. Advances in Experimental Medicine and Biology 515: 115-139
Roche, J.ël.; Drabkin, H.; Brambilla, E. 2002: Neuropilin and its ligands in normal lung and cancer. Advances in Experimental Medicine and Biology 515: 103-114
Romeo, P.-H.; Lemarchandel, V.ér.; Tordjman, R. 2002: Neuropilin-1 in the immune system. Advances in Experimental Medicine and Biology 515: 49-54
Feldner, J.; Becker, T.; Goishi, K.; Schweitzer, J.ör.; Lee, P.; Schachner, M.; Klagsbrun, M.; Becker, C.G. 2005: Neuropilin-1a is involved in trunk motor axon outgrowth in embryonic zebrafish. Developmental Dynamics: An Official Publication of the American Association of Anatomists 234(3): 535-549
Bagri, A.; Tessier-Lavigne, M. 2002: Neuropilins as Semaphorin receptors: in vivo functions in neuronal cell migration and axon guidance. Advances in Experimental Medicine and Biology 515: 13-31
Behrman, A.L.; Bowden, M.G.; Nair, P.M. 2006: Neuroplasticity after spinal cord injury and training: an emerging paradigm shift in rehabilitation and walking recovery. Physical Therapy 86(10): 1406-1425
Viallet, F.; Witjas, T. 2002: Neuroplasticity and Parkinson disease. Revue Neurologique (Paris) 158(Special Issue 1): S42-S48
Viallet, F..; Witjas, T.. 2002: Neuroplasticity and Parkinson's disease. Revue Neurologique (Paris) 158(122): 42-48
Levin, H.S. 2006: Neuroplasticity and brain imaging research: implications for rehabilitation. Archives of Physical Medicine and Rehabilitation 87(12 Suppl 2: S1
Mark, V.W.; Taub, E.; Morris, D.M. 2006: Neuroplasticity and constraint-induced movement therapy. Europa Medicophysica 42(3): 269-284
Hallett, M. 2005: Neuroplasticity and rehabilitation. Journal of Rehabilitation Research and Development 42(4): Xvii-Xxii
Skaper, S.D.; Leon, A.; Toffano, G. 1989: Neuroplasticity and repair following injury to the central nervous system. Journal of Neurosurgical Anesthesiology 1(4): 377-382
Stevens, C.; Neville, H. 2006: Neuroplasticity as a double-edged sword: deaf enhancements and dyslexic deficits in motion processing. Journal of Cognitive Neuroscience 18(5): 701-714
Slenzka, K. 2003: Neuroplasticity changes during space flight. Advances in Space Research: the Official Journal of the Committee on Space Research 31(6): 1595-1604
Gil-Loyzaga, P. 2005: Neuroplasticity in the auditory system. Revue de Laryngologie - Otologie - Rhinologie 126(4): 203-207
De Campora, E.; Bicciolo, G.; Tecchio, F.; Rossini, P.M. 2003: Neuroplasticity of auditory cortex after stape surgery for otosclerosis: a magnetoencephalographic study. Acta Otorhinolaryngologica Italica: Organo Ufficiale Della Societa Italiana di Otorinolaringologia e Chirurgia Cervico-Facciale 23(4): 243-250
Carey, J.R.; Bhatt, E.; Nagpal, A. 2005: Neuroplasticity promoted by task complexity. Exercise and Sport Sciences Reviews 33(1): 24-31
Balfour, D.J.K. 2002: Neuroplasticity within the mesoaccumbens dopamine system and its role in tobacco dependence. Current Drug Targets. Cns and Neurological Disorders 1(4): 413-421
Sunderland, A.; Tuke, A. 2005: Neuroplasticity, learning and recovery after stroke: a critical evaluation of constraint-induced therapy. Neuropsychological Rehabilitation 15(2): 81-96
Honsa, K. 1957: Neuroplegia and artificial hibernation in critical conditions in seriously injured patients. Anesthesie Analgesie Reanimation 14(5): 971-979
Bach, H.G. 1960: Neuroplegia ("vegetative blockade") as a therapeutic principle for the injured newborn infant. Archiv für Gynakologie 192: 437-449
Setbon, L.; Stroz, G. 1964: Neuroplegia Associated with Enzyme Inhibitors in the Treatment of Severe Hemorrhagic Acute Pancreatitis. Acta Gastro-Enterologica Belgica 27: 347-350
Martins, A.D. 1963: Neuroplegia Associated with Local Anesthesia in Obstetrical Operations. Revista de Ginecologia e d'Obstetricia 112: 27-30
Peri, M.; Peri, G. 1965: Neuroplegia in Stomatologic Surgery. Revue de Stomatologie 66: 68-72
Cuocolo, R.; Gismondi, A. 1956: Neuroplegia and adrenal cortex; experimental research. Giornale Italiano di Chirurgia 12(10): 585-596
Laborit, H. 1955: Neuroplegia and artificial hibernation. Maroc Medical 34(361): 797-802
Sartori, G. 1958: Neuroplegia and artificial hibernation as experienced by an anesthetist of a provincial hospital with special reference to the use of hydergine. Minerva Anestesiologica 24(3): 105-109
Bobbio, A.; Goffrini, P.; Bezzi, E.; Uleri, G. 1960: Neuroplegia and hypothermia in the management of surgical thyrotoxicosis. Journal of the International College of Surgeons 34: 372-379
Ranti, I.S.; Poesponegoro, S.D.; Te, B.S. 1960: Neuroplegia as an additional therapy of tetanus. Madjalah Kedokteran Indonesia 10: 425-433
Laborit, H. 1952: Neuroplegia in artificial hibernation. Gazette Medicale de France 59(23): 1423-1428
Couceiro, A. 1957: Neuroplegia in general surgery; neurolysis. El Dia Medico 29(16): 408; Passim
Feghali, A. 1954: Neuroplegia in pernicious attack of malaria in infants in Lebanon; method for use of combined lytic cocktails, and especially of dolosal, in pediatrics. La Presse Medicale 62(86): 1835
Wirth, W. 1954: Neuroplegia, potentiated anesthesia and controlled hypothermia; pharmacological remarks. Langenbecks Archiv für Klinische Chirurgie .. Vereinigt Mit Deutsche Zeitschrift für Chirurgie 279: 732-743
Contardi, J.C. 1959: Neuroplegia. Clinical applications. La Semana Medica 115(633): Passim
Braginskaia, V.P.; Zakharova, N.V. 1964: Neuroplegic Preparations in the Treatment of Whooping Cough. Pediatriia 43: 35-40
Dobrzhanskaia, A.K. 1964: Neuroplegic Therapy of Mental Disorders in Endocrine Diseases. Problemy Endokrinologii i Gormonoterapii 10: 41-48
Gori, E.; Frangipane, G. 1959: Neuroplegic activity of 2-alkyl-crotonylureas. Il Farmaco; Edizione Scientifica 14: 845-853
Petrov, I.R. 1957: Neuroplegic drugs and hypothermia in prevention and treatment of shock. Patologicheskaia Fiziologiia i Eksperimental'naia Terapiia 1(2): 18-25
Voiculescu, V. 1958: Neuroplegic drugs in diseases of the nervous system. Medicina Interna 10(4): 585-588
Cavazzuti, F.; Cristini, M. 1956: Neuroplegic drugs in the reparative treatment of cardiac decompensation. Atti Della Societa Italiana di Cardiologia 1: 384-386
Decortis, A. 1955: Neuroplegic medication and anticoagulants in severe cases of febrile coronary angina. Revue Medicale de Liege 10(6): 187-192
Pigeaud, H.; La Selve, A. 1955: Neuroplegic medication associated or not with induced lowering of the central temperature in the very weak premature infant. La Presse Medicale 63(24): 489-491
Delay, J.; Deniker, P.; Tardieu, Y.; Lemperiere, T. 1955: Neuroplegic medications and cures in psychiatry: preliminary trials with reserpine; comparison with the effects of chlorpromazine. La Presse Medicale 63(32): 663-665
Budinsky, J.; Stiksa, E.; Skrivan, J.; Fabianova, J. 1962: Neuroplegic obstetrical analgesia. Ceskoslovenska Gynekologie 27: 387-394
Novikova, N.M. 1961: Neuroplegic substance in combination with local anesthesia in surgery of cancer of the uterine corpus and cervix. Sovetskaia Meditsina 25: 40-43
Salet, J.; Berkman, M. 1955: Neuroplegic substances in the treatment of acute lung diseases in children causing dyspnea. La Semaine des Hopitaux: Organe Fonde Par l'Association d'Enseignement Medical des Hopitaux de Paris 31(5-1): 288-291
Laborit, H. 1954: Neuroplegic therapy and artificial hibernation: an attempt to clear up a misunderstanding. La Presse Medicale 62(17): 359-362
Broustet, P.; Bricaud, H.; Gazeau, J.; Cabanieu, J.; Honton 1955: Neuroplegic treatment of myocardial infarct, its painful sequelae and intractable pain. La Presse Medicale 63(85): 1761-1763
Matera, F.C.; Alvarez, A.R.; Badia, I.; Bugarini, H.; Landoni, J.F.; Mesz, B.; Mendilharzu, F.; Mandilharzu, J.L.; Murad, J.; Quintana, H. 1957: Neuroplegic treatment of poliomyelitis. Anesthesie Analgesie Reanimation 14(2): 254-259
Mueller, M.; Kiesewetter, R. 1959: Neuroplegics. Die Pharmazie 14: 361-371
Dolecek, R.; Endryas, L.; Kalina, J.; Klabusay, L.; Jezek, M. 1965: Neuroplegics in the Treatment of Burns: Experimental and Clinical Results. Journal of Trauma 5: 24-42
Gasparri, F.; Ogier, E. 1955: Neuroplegics and bromocalcic therapy in labor analgesia. Rivista di Ostetricia e Ginecologia 10(11): 772-784
Dolecek, R.; Kalina, J.; Klabusay, L. 1959: Neuroplegics and hormones in the treatment of burns. Acta Chirurgiae Plasticae 1: 115-139
Raffo Uzategui, A.; Callegari Morin, A. 1957: Neuroplegics and spinal analgesia. Revista Espanola de Anestesiologia 4(1): 62-64
Canfora, A. 1962: Neuroplegics and the biological diagnosis of pregnancy in legal medicine. Folia Medica. Folia Medica 45: 944-954
Santopadre, I.; Silanos, G. 1959: Neuroplegics as a therapeutic aid in treatment of tuberculous meningitis. La Clinica Pediatrica 41: 925-936
Weyer, H.; Rohl, C. 1959: Neuroplegics as adjunctive therapy of skin diseases. Deutsches Medizinisches Journal 10(4): 78-82
Weirich, E.G. 1961: Neuroplegics in dermiatrics. Die Medizinische Welt 18: 976-980
Weirich, E.G. 1961: Neuroplegics in dermiatrics. (I). Die Medizinische Welt 17: 914-918
Baumann, E. 1959: Neuroplegics in internal medicine with special reference to phasein. Medizinische Klinik 54(5): 170-174
Delay, J.; Deniker, P. 1953: Neuroplegics in psychiatric therapy. Therapie 8(3): 347-364
Havlin, I.; Honsa, K. 1957: Neuroplegics in the treatment of hyperthermia caused by cervical cord injuries. Chirurgia Narzadow Ruchu i Ortopedia Polska 22(4): 455-458
Salomone, F.P.; Peria, G.; Rodolico, G.; Cacoiola, R. 1955: Neuroplegics in therapy of pain. Minerva Chirurgica 10(7): 296
Fidelin, C. 1955: Neuroplegics in therapy of pernicious malarial attacks. La Presse Medicale 63(19): 390
Herbst, R. 1956: Neuroplegics, or ganglion-blocking substances, in therapy of internal diseases. Deutsches Medizinisches Journal 7(8): 229-232
Cutica, I.; Bucciarelli, M.; Bara, B.G. 2006: Neuropragmatics: Extralinguistic pragmatic ability is better preserved in left-hemisphere-damaged patients than in right-hemisphere-damaged patients. Brain and Language 98(1): 12-25
Park, T.-S.; Kim, Y.-S. 2005: Neuropraxia of the cutaneous nerve of the cervical plexus after shoulder arthroscopy. Arthroscopy: the Journal of Arthroscopic and Related Surgery: Official Publication of the Arthroscopy Association of North America and the International Arthroscopy Association 21(5): 631
Akhtar, S.; Arenas Prat, J.; Sinha, S. 2005: Neuropraxia of the palmar cutaneous branch of the ulnar nerve during carpal tunnel decompression. Annals of the Royal College of Surgeons of England 87(3): W1-W2
Mittendorf, R.; Pyrde, P.G. 2006: Neuroprophylaxis with aminophylline and magnesium sulfate?. American Journal of Obstetrics and Gynecology 194(2): 593; Author Reply 594
Rupp, R.; Gerner, H.J. 2004: Neuroprosthetics of the upper extremity--clinical application in spinal cord injury and future perspectives. Biomedizinische Technik. Biomedical Engineering 49(4): 93-98
Wickelgren, I. 2004: Neuroprosthetics. Brain-computer interface adds a new dimension. Science 306(5703): 1878-1879
Hook, V.Y.H. 2006: Neuroproteases in peptide neurotransmission and neurodegenerative diseases: applications to drug discovery research. Biodrugs: Clinical Immunotherapeutics Biopharmaceuticals and Gene Therapy 20(2): 105-119
Menon, D.K.; Summors, A.C. 1998: Neuroprotection (including hypothermia). Current Opinion in Anaesthesiology 11(5): 485-496
Farooqui, A.A.; Ong, W-Yi.; Horrocks, L.A. 2004: Neuroprotection abilities of cytosolic phospholipase A2 inhibitors in kainic acid-induced neurodegeneration. Current Drug Targets. Cardiovascular and Haematological Disorders 4(1): 85-96
Egea, J.; Rosa, A.O.; Sobrado, M.; Gandía, L.; López, M.G.; García, A.G. 2007: Neuroprotection afforded by nicotine against oxygen and glucose deprivation in hippocampal slices is lost in alpha7 nicotinic receptor knockout mice. Neuroscience 145(3): 866-872
Al-Senani, F.M.; Grotta, J.C. 2002: Neuroprotection after cardiac arrest. LANCET. Neurology 1(3): 146
Paula-Lima, A.éa.C.; Louzada, P.R.; De Mello, F.G.; Ferreira, S.ér.T. 2003: Neuroprotection against Abeta and glutamate toxicity by melatonin: are GABA receptors involved?. Neurotoxicity Research 5(5): 323-327
Osborne, N.N.; Schmidt, K.-G. 2004: Neuroprotection against glaucoma remains a concept. Der Ophthalmologe: Zeitschrift der Deutschen Ophthalmologischen Gesellschaft 101(11): 1087-1092
Smith, P.F. 2003: Neuroprotection against hypoxia-ischemia by insulin-like growth factor-i (IGF-I). Idrugs: the Investigational Drugs Journal 6(12): 1173-1177
Mækelæ, M.J.; Moritz, S.; Pfuhl, G. 2018: Are Psychotic Experiences Related to Poorer Reflective Reasoning?. Frontiers in Psychology 9: 122
Hall, E.D.; Springer, J.E. 2004: Neuroprotection and acute spinal cord injury: a reappraisal. Neurorx: the Journal of the American Society for Experimental Neurotherapeutics 1(1): 80-100
Genovese, T.; Mazzon, E.; Menegazzi, M.; Di Paola, R.; Muià, C.; Crisafulli, C.; Bramanti, P.; Suzuki, H.; Cuzzocrea, S. 2006: Neuroprotection and enhanced recovery with hypericum perforatum extract after experimental spinal cord injury in mice. Shock 25(6): 608-617
Dwyer, D.S.; Dickson, A. 2007: Neuroprotection and enhancement of neurite outgrowth with small molecular weight compounds from screens of chemical libraries. International Review of Neurobiology 77: 247-289
Halász, Péter.; Rásonyi, Görgy. 2004: Neuroprotection and epilepsy. Advances in Experimental Medicine and Biology 541: 91-109
Colak, A.; Karaoğlan, A.; Barut, S.; Köktürk, S.; Akyildiz, Aşenur.Iğdem.; Taşyürekli, M. 2005: Neuroprotection and functional recovery after application of the caspase-9 inhibitor z-LEHD-fmk in a rat model of traumatic spinal cord injury. Journal of Neurosurgery. Spine 2(3): 327-334
Ziemssen, T. 2004: Neuroprotection and glatiramer acetate: the possible role in the treatment of multiple sclerosis. Advances in Experimental Medicine and Biology 541: 111-134
Akwa, Y.; Allain, H.é; Bentue-Ferrer, D.èl.; Berr, C.; Bordet, R.ég.; Geerts, H.; Nieoullon, A.é; Onteniente, B.; Vercelletto, M. 2005: Neuroprotection and neurodegenerative diseases: from biology to clinical practice. Alzheimer Disease and Associated Disorders 19(4): 226-239
Kingston, A. 2000: Neuroprotection and neurorepair. 2-4 March 2000, Magdeburg, Germany. IDrugs: the investigational drugs journal 3(6): 623-625
Clarke, C.E. 2004: Neuroprotection and pharmacotherapy for motor symptoms in Parkinson's disease. LANCET. Neurology 3(8): 466-474
Levin, L.A. 2005: Neuroprotection and regeneration in glaucoma. Ophthalmology Clinics of North America 18(4): 585-596 Vii
Romero, Jé.Rafael.; Babikian, V.L.; Katz, D.I.; Finklestein, S.P. 2006: Neuroprotection and stroke rehabilitation: modulation and enhancement of recovery. Behavioural Neurology 17(1): 17-24
Ly, J.V.; Zavala, J.A.; Donnan, G.A. 2006: Neuroprotection and thrombolysis: combination therapy in acute ischaemic stroke. Expert Opinion on PharmacoTherapy 7(12): 1571-1581
Ignat, F. 2004: Neuroprotection and vasoprotection in glaucoma. Oftalmologia 48(2): 5-14
Williams, A.J.; Lu, X.-C.M.; Hartings, J.A.; Tortella, F.C. 2003: Neuroprotection assessment by topographic electroencephalographic analysis: effects of a sodium channel blocker to reduce polymorphic delta activity following ischaemic brain injury in rats. Fundamental and Clinical Pharmacology 17(5): 581-593
Damian, M.S. 2004: Neuroprotection becomes reality: changing times for cerebral resuscitation. Advances in Experimental Medicine and Biology 550: 143-150
Frenkel, D.; Huang, Z.; Maron, R.; Koldzic, D.N.; Moskowitz, M.A.; Weiner, H.L. 2005: Neuroprotection by IL-10-producing MOG CD4+ T cells following ischemic stroke. Journal of the Neurological Sciences 233(1-2): 125-132
Tabakman, R.; Jiang, H.; Shahar, I.; Arien-Zakay, H.; Levine, R.A.; Lazarovici, P. 2005: Neuroprotection by NGF in the PC12 in vitro OGD model: involvement of mitogen-activated protein kinases and gene expression. Annals of the new York Academy of Sciences 1053: 84-96
Hemmings, H.C. 2004: Neuroprotection by Na+ channel blockade. Journal of Neurosurgical Anesthesiology 16(1): 100-101
Shachar, D.B.; Kahana, N.; Kampel, V.; Warshawsky, A.; Youdim, M.B.H. 2004: Neuroprotection by a novel brain permeable iron chelator, VK-28, against 6-hydroxydopamine lession in rats. Neuropharmacology 46(2): 254-263
Silveira, M.S.; Linden, R. 2006: Neuroprotection by cAMP: Another brick in the wall. Advances in Experimental Medicine and Biology 557: 164-176
Bains, M.; Cousins, J.C.; Roberts, J.L. 2007: Neuroprotection by estrogen against MPP+-induced dopamine neuron death is mediated by ERalpha in primary cultures of mouse mesencephalon. Experimental Neurology 204(2): 767-776
Merchenthaler, I.; Dellovade, T.L.; Shughrue, P.J. 2003: Neuroprotection by estrogen in animal models of global and focal ischemia. Annals of the new York Academy of Sciences 1007: 89-100
Grimm, C.; Hermann, D.M.; Bogdanova, A.; Hotop, S.; Kilic, U.; Wenzel, A.; Kilic, E.; Gassmann, M. 2005: Neuroprotection by hypoxic preconditioning: HIF-1 and erythropoietin protect from retinal degeneration. Seminars in Cell and Developmental Biology 16(4-5): 531-538
Vereshchagin, E.I.; Tarasov, R.S.; Astrakov, S.V.; Lokotkova, O.V.; Egorov, A.V.; Volkov, S.G.; Vereshchagin, I.P. 2004: Neuroprotection by ketamine and dopamine-saving drugs in severe craniocerebral trauma at exacerbation and in the treatment of apallic syndrome. Anesteziologiia i Reanimatologiia 4: 54-56
Rosa, A.O.; Egea, J.; Gandía, L.ís.; López, M.G.; García, A.G. 2006: Neuroprotection by nicotine in hippocampal slices subjected to oxygen-glucose deprivation: involvement of the alpha7 nAChR subtype. Journal of Molecular Neuroscience: Mn 30(1-2): 61-62
Liu, W.-G.; Chen, Y.; Li, B.; Lu, G.-Q.; Chen, S.-D. 2004: Neuroprotection by pergolide against levodopa-induced cytotoxicity of neural stem cells. Neurochemical Research 29(12): 2207-2214
Tian, X.; Bazan, N.G. 2005: Neuroprotection by platelet-activating factor antagonism. Annals of the new York Academy of Sciences 1053: 455-456
Blandini, F. 2005: Neuroprotection by rasagiline: a new therapeutic approach to Parkinson's disease?. Cns Drug Reviews 11(2): 183-194
Dhandapani, K.M.; Wade, F.M.; Wakade, C.; Mahesh, V.B.; Brann, D.W. 2005: Neuroprotection by stem cell factor in rat cortical neurons involves AKT and NFkappaB. Journal of Neurochemistry 95(1): 9-19
Ward, R.; Cirkovic-Vellichovia, T.; Ledeque, F.; Tirizitis, G.; Dubars, G.; Datla, K.; Dexter, D.; Heushling, P.; Crichton, R. 2006: Neuroprotection by taurine and taurine analogues. Advances in Experimental Medicine and Biology 583: 299-306
Mehta, S.H.; Webb, R.C.; Ergul, A.; Tawfik, A.; Dorrance, A.M.; Tawak, A. 2004: Neuroprotection by tempol in a model of iron-induced oxidative stress in acute ischemic stroke. American Journal of Physiology. Regulatory Integrative and Comparative Physiology 286(2): R283-R288
Bezard, E. 2003: Neuroprotection for Parkinson's disease: a call for clinically driven experimental design. LANCET. Neurology 2(7): 393
Hankey, G.J. 2006: Neuroprotection for acute ischaemic stroke: hope reignited. Lancet. Neurology 5(4): 287-288
Hinkle, J.L.; Bowman, L. 2003: Neuroprotection for ischemic stroke. Journal of Neuroscience Nursing: Journal of the American Association of Neuroscience Nurses 35(2): 114-118
Konstas, A.-A.; Choi, J.H.; Pile-Spellman, J. 2006: Neuroprotection for ischemic stroke using hypothermia. Neurocritical Care 4(2): 168-178
Cheng, Y.D.; Al-Khoury, L.; Zivin, J.A. 2004: Neuroprotection for ischemic stroke: two decades of success and failure. Neurorx: the Journal of the American Society for Experimental Neurotherapeutics 1(1): 36-45
Kulkarni, A.P.; Kellaway, L.A.; Lahiri, D.K.; Kotwal, G.J. 2004: Neuroprotection from complement-mediated inflammatory damage. Annals of the new York Academy of Sciences 1035: 147-164
Liebeskind, D.S. 2005: Neuroprotection from the collateral perspective. Idrugs: the Investigational Drugs Journal 8(3): 222-228
Nordberg, A. 2000: Neuroprotection in Alzheimer's disease - new strategies for treatment. Neurotoxicity Research 2(2-3): 157-165
Lahousen, T.; Bonelli, R.M. 2003: Neuroprotection in Huntington's [correction of Hungtington's] disease. Clinical neuropharmacology 26(5): 223-4; author reply 224
Schapira, A.H.V. 2003: Neuroprotection in PD--a role for dopamine agonists?. Neurology 61(6 Suppl 3: S34-S42
Schapira, A.H.V.; Olanow, C.W. 2004: Neuroprotection in Parkinson disease: mysteries, myths, and misconceptions. JAMA 291(3): 358-364
Lang, A.E. 2006: Neuroprotection in Parkinson's disease: and now for something completely different?. Lancet. Neurology 5(12): 990-991
Fu, E.S.; Tummala, R.P. 2005: Neuroprotection in brain and spinal cord trauma. Current Opinion in Anaesthesiology 18(2): 181-187
Zádor, Z.; Benyó, Z.án.; Lacza, Z.; Hortobágyi, T.; Harkány, T.; Hortobágyi, T. 2004: Neuroprotection in brain ischemia--doubts and hopes. Ideggyogyaszati Szemle 57(3-4): 81-93
Schaller, B. 2003: Neuroprotection in brain tumors. Good sense or nonsense from the pathophysiological viewpoint?. Der Nervenarzt 74(12): 1134-1136
Baumgartner, W.A. 2005: Neuroprotection in cardiac surgery. Annals of Thoracic Surgery 79(6): S2254-S2256
Wahlgren, N.G.; Ahmed, N. 2004: Neuroprotection in cerebral ischaemia: facts and fancies--the need for new approaches. Cerebrovascular Diseases 17(Suppl 1): 153-166
Sankar, R. 2005: Neuroprotection in epilepsy: the Holy Grail of antiepileptogenic therapy. Epilepsy and Behavior: E&b 7(Suppl 3): S1-S2
Wu, D. 2005: Neuroprotection in experimental stroke with targeted neurotrophins. Neurorx: the Journal of the American Society for Experimental Neurotherapeutics 2(1): 120-128
Marcic, T.S.; Belyea, D.A.; Katz, B. 2003: Neuroprotection in glaucoma: a model for neuroprotection in optic neuropathies. Current Opinion in Ophthalmology 14(6): 353-356
Schöller, K.; Zausinger, S.; Baethmann, A.; Schmid-Elsaesser, R. 2004: Neuroprotection in ischemic stroke--combination drug therapy and mild hypothermia in a rat model of permanent focal cerebral ischemia. Brain Research 1023(2): 272-278
Nagy, Z.án.; Simon, L.ás.ó 2004: Neuroprotection in ischemic/hypoxic disorders: from the preclinical to the clinical testing. Advances in Experimental Medicine and Biology 541: 39-54
Delgado, P.; Sahuquillo, J.; Poca, M.A.; Alvarez-Sabin, J.é 2006: Neuroprotection in malignant MCA infarction. Cerebrovascular Diseases 21(Suppl 2): 99-105
Karussis, D.; Grigoriadis, S.; Polyzoidou, E.; Grigoriadis, N.; Slavin, S.; Abramsky, O. 2006: Neuroprotection in multiple sclerosis. Clinical Neurology and Neurosurgery 108(3): 250-254
Kapoor, R. 2006: Neuroprotection in multiple sclerosis: therapeutic strategies and clinical trial design. Current Opinion in Neurology 19(3): 255-259
Schaller, B.J.; Buchfelder, M. 2006: Neuroprotection in primary brain tumors: sense or nonsense?. Expert Review of Neurotherapeutics 6(5): 723-730
Djaldetti, R.; Lev, N.; Melamed, E. 2003: Neuroprotection in progressive brain disorders. Israel Medical Association Journal: Imaj 5(8): 576-580
Höke, A.; Keswani, S.C. 2005: Neuroprotection in the PNS: erythropoietin and immunophilin ligands. Annals of the new York Academy of Sciences 1053: 491-501
Schouten, J.W. 2007: Neuroprotection in traumatic brain injury: a complex struggle against the biology of nature. Current Opinion in Critical Care 13(2): 134-142
Martínez-Vila, E.; Murie-Fernández, M.; Gállego Pérez-Larraya, J.; Irimia, P. 2006: Neuroprotection in vascular dementia. Cerebrovascular Diseases 21(Suppl 2): 106-117
Singh, J.; Kaur, G. 2005: Neuroprotection mediated by subtoxic dose of NMDA in SH-SY5Y neuroblastoma cultures: activity-dependent regulation of PSA-NCAM expression. Brain Research. Molecular Brain Research 137(1-2): 223-234
Reyes, O.; Sosa, I.; Kuffler, D.P. 2006: Neuroprotection of adult human neurons against ischemia by hypothermia and alkalinization. Puerto Rico Health Sciences Journal 25(1): 43-50
Chang, Q.-z.; Hu, D.-h.; Chen, M.; Wang, Y.; Gao, T.-m. 2006: Neuroprotection of chloride channel blockers against NMDA-induced apoptosis of cultured rat hippocampal neurons. Nan Fang Yi Ke da Xue Xue Bao 26(2): 158-161
Adcock, K.H.; Nedelcu, J.; Loenneker, T.; Martin, E.; Wallimann, T.; Wagner, B.P. 2002: Neuroprotection of creatine supplementation in neonatal rats with transient cerebral hypoxia-ischemia. Developmental Neuroscience 24(5): 382-388
Yang, F.; Li, J.; Yang, F. 2004: Neuroprotection of lithium and the antagonism of lithium to toxic effects of lead on primary culturing cerebrocortical neurons in vitro. Wei Sheng Yan Jiu 33(6): 671-674
Sun, X.-d.; Zhang, X.; Xu, X.; Yu, Z.; Chen, R.-j. 2003: Neuroprotection of nerve growth factor in experiment retinal detachment. Chinese Journal of Ophthalmology 39(5): 303-307
Sahel, J.é-A.; Mohand-Said, S.; Léveillard, T. 2005: Neuroprotection of photoreceptor cells in rod-cone dystrophies: from cell therapy to cell signalling. Comptes Rendus Biologies 328(2): 163-168
Pardue, M.T.; Phillips, M.J.; Hanzlicek, B.; Yin, H.; Chow, A.Y.; Ball, S.L. 2006: Neuroprotection of photoreceptors in the RCS rat after implantation of a subretinal implant in the superior or inferior retina. Advances in Experimental Medicine and Biology 572: 321-326
Strokin, M.; Chechneva, O.; Reymann, K.G.; Reiser, G. 2006: Neuroprotection of rat hippocampal slices exposed to oxygen-glucose deprivation by enrichment with docosahexaenoic acid and by inhibition of hydrolysis of docosahexaenoic acid-containing phospholipids by calcium independent phospholipase A2. Neuroscience 140(2): 547-553
Reyes, O.; Sosa, I.; Kuffler, D.P. 2003: Neuroprotection of spinal neurons against blunt trauma and ischemia. Puerto Rico Health Sciences Journal 22(3): 277-286
Takumida, M.; Anniko, M.; Shimizu, A.; Watanabe, H. 2003: Neuroprotection of vestibular sensory cells from gentamicin ototoxicity obtained using nitric oxide synthase inhibitors, reactive oxygen species scavengers, brain-derived neurotrophic factors and calpain inhibitors. Acta Oto-Laryngologica 123(1): 8-13
Artemowicz, B.; Sobaniec, W. 2005: Neuroprotection possibilities in epileptic children. Roczniki Akademii Medycznej W Bialymstoku 50(Suppl 1): 91-95
Pereira, C.áu.; Agostinho, P.; Moreira, P.I.; Duarte, A.I.; Santos, M.S.; Oliveira, C.R. 2003: Neuroprotection strategies: effect of vinpocetine in vitro oxidative stress models. Acta Medica Portuguesa 16(6): 401-406
Wang, K.K.W.; Larner, S.F.; Robinson, G.; Hayes, R.L. 2006: Neuroprotection targets after traumatic brain injury. Current Opinion in Neurology 19(6): 514-519
Andrews, R.J. 2003: Neuroprotection trek--the next generation: neuromodulation I. Techniques--deep brain stimulation, vagus nerve stimulation, and transcranial magnetic stimulation. Annals of the new York Academy of Sciences 993: 1-13; Discussion: 48-53
Andrews, R.J. 2003: Neuroprotection trek--the next generation: neuromodulation II. Applications--epilepsy, nerve regeneration, neurotrophins. Annals of the new York Academy of Sciences 993: 14-24; Discussion: 48-53
Andrews, R.J. 2005: Neuroprotection trek--the next generation: the measurement is the message. Annals of the new York Academy of Sciences 1053: 1-11
Hilpert, F.; Stähle, A.; Tomé, O.; Burges, A.; Rossner, D.; Späthe, K.; Heilmann, V.; Richter, B.; du Bois, A. 2005: Neuroprotection with amifostine in the first-line treatment of advanced ovarian cancer with carboplatin/paclitaxel-based chemotherapy--a double-blind, placebo-controlled, randomized phase Ii study from the Arbeitsgemeinschaft Gynäkologische Onkologoie (AGO) Ovarian Cancer Study Group. Supportive Care in Cancer: Official Journal of the Multinational Association of Supportive Care in Cancer 13(10): 797-805
Hans, P.; Bonhomme, V. 2001: Neuroprotection with anaesthetic agents. Current Opinion in Anaesthesiology 14(5): 491-496
Wilms, H.; Rosenstiel, P.; Unger, T.; Deuschl, G.ün.; Lucius, R. 2005: Neuroprotection with angiotensin receptor antagonists: a review of the evidence and potential mechanisms. American Journal of Cardiovascular Drugs: Drugs Devices and other Interventions 5(4): 245-253
Neacşu, A.; Oprean, C.; Curea, M.; Tuchilă, G.; Trifu, M. 2003: Neuroprotection with carotenoids in glaucoma. Oftalmologia 59(4): 70-75
Lawrence, E.J.; Dentcheva, E.; Curtis, K.M.; Roberts, V.L.; Siman, R.; Neumar, R.W. 2005: Neuroprotection with delayed initiation of prolonged hypothermia after in vitro transient global brain ischemia. Resuscitation 64(3): 383-388
Thajeb, P.; Kuo, J.-S.; Shyu, W.-C.; Lin, S.-Z. 2006: Neuroprotection with methylaminochroman and lazaroid of embryonic ventral mesencephalic tegmental dopaminergic neurons in cold storage. Journal of Clinical Neuroscience: Official Journal of the Neurosurgical Society of Australasia 13(4): 467-470
Williams, A.J.; Dave, J.R.; Tortella, F.C. 2006: Neuroprotection with the proteasome inhibitor MLN519 in focal ischemic brain injury: relation to nuclear factor kappaB (NF-kappaB), inflammatory gene expression, and leukocyte infiltration. Neurochemistry International 49(2): 106-112
Calzà, L.; Giardino, L. 2004: Neuroprotection: a realistic goal for aged brain?. Advances in Experimental Medicine and Biology 541: 153-168
Lieberman, J.A.; Perkins, D.O.; Jarskog, L.Fredrik. 2007: Neuroprotection: a therapeutic strategy to prevent deterioration associated with schizophrenia. Cns Spectrums 12(3 Suppl. 4): 1-13; Quiz 14
Memo, M.; Blandini, F.; Nappi, G.; Spano, P. 2002: Neuroprotection: promise and pitfalls in anti-inflammatory treatment of Alzheimer's disease. Functional Neurology 17(4): 175-176
Sharma, S.; Kheradpezhou, M.; Shavali, S.; El Refaey, H.; Eken, J.; Hagen, C.; Ebadi, M. 2004: Neuroprotective actions of coenzyme Q10 in Parkinson's disease. Methods in Enzymology 382: 488-509
Van Kampen, J.; Robertson, H.; Hagg, T.; Drobitch, R. 2003: Neuroprotective actions of the ginseng extract G115 in two rodent models of Parkinson's disease. Experimental Neurology 184(1): 521-529
Jiang, Z.-G.; Lebowitz, M.S.; Ghanbari, H.A. 2006: Neuroprotective activity of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (PAN-811), a cancer therapeutic agent. Cns Drug Reviews 12(1): 77-90
Flor, P.J.; Battaglia, G.; Nicoletti, F.; Gasparini, F.; Bruno, V. 2002: Neuroprotective activity of metabotropic glutamate receptor ligands. Advances in Experimental Medicine and Biology 513: 197-223
Romanova, G.A.; Voronina, T.A.; Dugina, Y.L.; Martyushev-Poklad, A.V.; Sergeeva, S.A.; Epstein, O.I.; Barskov, I.V. 2005: Neuroprotective activity of proproten in rats with experimental local photothrombosis of the prefrontal cortex. Bulletin of Experimental Biology and Medicine 139(4): 404-407
Garrity-Moses, M.E.; Teng, Q.; Liu, J.; Tanase, D.; Boulis, N.M. 2005: Neuroprotective adeno-associated virus Bcl-xL gene transfer in models of motor neuron disease. Muscle and Nerve 32(6): 734-744
Burke, W.J. 2007: Neuroprotective agents for clinical trials in ALS: systematic assessment. Neurology 68(9): 709; Author Reply 710
Hälbig, T.D.; Tse, W.; Olanow, C.W. 2004: Neuroprotective agents in Parkinson's disease: clinical evidence and caveats. Neurologic Clinics 22(3 Suppl): S1-S17
Krebs, M.; Leopold, K.; Hinzpeter, A.; Schaefer, M. 2006: Neuroprotective agents in schizophrenia and affective disorders. Expert Opinion on PharmacoTherapy 7(7): 837-848
Freitas, G.R.de.; Noujaim, J.El.Kadum.; Haussen, Sérgio.R.; Yamamoto, Fábio.I.; Novak, E.M.; Gagliardi, R.J. 2005: Neuroprotective agents in stroke: national opinion. Arquivos de Neuro-Psiquiatria 63(3b): 889-891
De Witte, P.; Littleton, J.; Parot, P.; Koob, G. 2005: Neuroprotective and abstinence-promoting effects of acamprosate: elucidating the mechanism of action. Cns Drugs 19(6): 517-537
Barnstable, C.J.; Tombran-Tink, J. 2004: Neuroprotective and antiangiogenic actions of PEDF in the eye: molecular targets and therapeutic potential. Progress in Retinal and Eye Research 23(5): 561-577
Mirzoian, R.S. 2003: Neuroprotective and cerebrovascular effects of GABA mimetics. Eksperimental'naia i Klinicheskaia Farmakologiia 66(2): 53-56
Crandall, J.; Matragoon, S.; Khalifa, Y.M.; Borlongan, C.; Tsai, N-Tse.; Caldwell, R.B.; Liou, G.I. 2007: Neuroprotective and intraocular pressure-lowering effects of (-)Delta9-tetrahydrocannabinol in a rat model of glaucoma. Ophthalmic Research 39(2): 69-75
Beal, M.F.; Palomo, T.; Kostrzewa, R.M.; Archer, T. 2000: Neuroprotective and neurorestorative strategies for neuronal injury. Neurotoxicity Research 2(2-3): 71-84
Garbayo, E.; Aymerich, M.S.; Ansorena, E.; Lanciego, J.L.; Blanco-Prieto, M.J. 2006: Neuroprotective and neurorestorative therapies for the treatment of Parkinson's disease. Anales del Sistema Sanitario de Navarra 29(3): 325-335
Chuang, D.-M. 2004: Neuroprotective and neurotrophic actions of the mood stabilizer lithium: can it be used to treat neurodegenerative diseases?. Critical Reviews in Neurobiology 16(1-2): 83-90
Danysz, W.; Parsons, C.G.; Mobius, H.J.; Stoffler, A.; Quack, G. 2000: Neuroprotective and symptomatological action of memantine relevant for Alzheimer's disease--a unified glutamatergic hypothesis on the mechanism of action. Neurotoxicity Research 2(2-3): 85-97
Zhu, C.-l.; Wang, X.-y.; Cheng, X.-y.; Qiu, L.; Hu, S.-h.; Yang, J.-l.; Xu, F.-l. 2003: Neuroprotective effect and mechanisms of hypothermia in neonatal rat cerebral hypoxic-ischemic damages. Zhonghua Er Ke Za Zhi 41(12): 911-915
Dohi, K.; Satoh, K.; Ikeda, Y.; Ohtaki, H.; Shioda, S.; Aruga, T. 2003: Neuroprotective effect from ischemia and direct free radical scavenging activity of Choto-san (kampo medicine). Acta Neurochirurgica. Suppl 86: 123-127
Hayashi, Y.; Kitaoka, Y.; Munemasa, Y.; Ohtani-Kaneko, R.; Kikusui, T.; Uematsu, A.; Takeda, H.; Hirata, K.; Mori, Y.; Ueno, S. 2007: Neuroprotective effect of 17beta-estradiol against N-methyl-D-aspartate-induced retinal neurotoxicity via p-ERK induction. Journal of Neuroscience Research 85(2): 386-394
Tian, J.; Fu, F.; Geng, M.; Jiang, Y.; Yang, J.; Jiang, W.; Wang, C.; Liu, K. 2005: Neuroprotective effect of 20(S)-ginsenoside Rg3 on cerebral ischemia in rats. Neuroscience Letters 374(2): 92-97
Sekita-Krzak, J.; Czerny, K.; Zebrowska-Łupina, I.; Stepniewska, M.; Visconti, J.óz.; Koziej, J. 2002: Neuroprotective effect of ACTH (4-9) in degeneration of hippocampal nerve cells caused by dexamethasone: morphological studies. Annales Universitatis Mariae Curie-Sklodowska. Sectio D: Medicina 57(2): 245-253
Luo, X.-l.; Mao, M.; Zhou, H.; Sun, X.-m.; Li, S.-f. 2006: Neuroprotective effect of BDNF on hypoxia for embryonic rat cortical neurons in vitro. Sichuan da Xue Xue Bao. Yi Xue Ban 37(3): 373-377
Ignat, F.; Damian, C.; Mănescu, R.; Perovic, I. 2002: Neuroprotective effect of Betoptic S-considerations after 18 months of treatment. Oftalmologia 52(1): 75-80
Chang, C.-Z.; Yen, C.-P.; Winadi, D.; Wu, S.-C.; Howng, S.-L.; Lin, T.-K.; Jeng, A.Y.; Kassell, N.F.; Kwan, A.-L. 2004: Neuroprotective effect of CGS 26303, an endothelin-converting enzyme inhibitor, on transient middle cerebral artery occlusion in rats. Journal of Cardiovascular Pharmacology 44(Suppl 1): S487-S489
Song, X.; Wu, B.; Takata, T.; Wang, X.; Oizumi, X.-S.; Akisaki, T.; Yokono, K.; Sakurai, T. 2005: Neuroprotective effect of D-fructose-1,6-bisphosphate against beta-amyloid induced neurotoxicity in rat hippocampal organotypic slice culture: involvement of PLC and MEK/ERK signaling pathways. Kobe Journal of Medical Sciences 51(5-6): 73-83
Silva, B.A.; Dias, A.C.P.; Ferreres, F.; Malva, J.ão.O.; Oliveira, C.R. 2004: Neuroprotective effect of H. perforatum extracts on beta-amyloid-induced neurotoxicity. Neurotoxicity Research 6(2): 119-130
Lee, C-Ha.; Choi, K.Young.; Kim, Y.Jin.; Kim, W.Gon. 2005: Neuroprotective effect of KR-31378, a novel potassium channel activator, on spinal cord ischemic injury in rabbits. Journal of Investigative Surgery: the Official Journal of the Academy of Surgical Research 18(6): 297-304
Cakir, O.; Erdem, K.; Oruc, A.; Kilinc, N.; Eren, N. 2003: Neuroprotective effect of N-acetylcysteine and hypothermia on the spinal cord ischemia-reperfusion injury. Cardiovascular Surgery 11(5): 375-379
Hula, N.M.; Marhitych, V.M.; Artamonov, M.V.; Zhukov, O.D.; Horid'ko, T.M.; Klimashevs'kyĭ, V.M. 2004: Neuroprotective effect of N-acylethanolamines in chronic morphine dependence. I. Rat brain phospholipids as a target of their action. Ukrains'kyi Biokhimichnyi Zhurnal 76(5): 123-131
Hula, N.M.; Marhitych, V.M.; Klimashevs'kyĭ, V.M.; Horid'ko, T.M.; Artamonov, M.V.; Zhukov, O.D. 2005: Neuroprotective effect of N-acylethanolamines in chronic morphine dependence. II. Effect on the rat brain fatty acid composition. Ukrains'kyi Biokhimichnyi Zhurnal 77(2): 112-117
Hula, N.M.; Huliĭ, M.F.; Kharchenko, N.K.; Horid'ko, T.M.; Marhitych, V.M. 2005: Neuroprotective effect of N-acylethanolamines in chronic morphine dependence. III. Influence on the content of neurotransmitters in the rat brain. Ukrains'kyi Biokhimichnyi Zhurnal 77(1): 47-51
Smiałowska, M.; Wierońska, J.M.; Szewczyk, B. 2003: Neuroprotective effect of NPY on kainate neurotoxicity in the hippocampus. Polish Journal of Pharmacology 55(6): 979-986
Seki, T.; Nakatani, M.; Taki, C.; Shinohara, Y.; Ozawa, M.; Nishimura, S.; Ito, H.; Shioda, S. 2006: Neuroprotective effect of PACAP against kainic acid-induced neurotoxicity in rat retina. Annals of the new York Academy of Sciences 1070: 531-534
Orellana, D.I.; Quintanilla, R.A.; Maccioni, R.B. 2007: Neuroprotective effect of TNFalpha against the beta-amyloid neurotoxicity mediated by CDK5 kinase. Biochimica et Biophysica Acta 1773(2): 254-263
Krylova, I.B.; Bulion, V.V.; Gavrovskaya, L.K.; Selina, E.N.; Kuznetzova, N.N.; Sapronov, N.S. 2006: Neuroprotective effect of a new taurinamide derivative--Taurepar. Advances in Experimental Medicine and Biology 583: 543-550
Fujimura, M.; Tominaga, T.; Chan, P.H. 2005: Neuroprotective effect of an antioxidant in ischemic brain injury: involvement of neuronal apoptosis. Neurocritical Care 2(1): 59-66
Kulinskiĭ, V.I.; Gavrilov, S.S. 2006: Neuroprotective effect of antipsychotic drugs (neuroleptics) in global brain ischemia. Eksperimental'naia i Klinicheskaia Farmakologiia 69(4): 19-22
Iuvone, T.; Esposito, G.; Esposito, R.; Santamaria, R.; Di Rosa, M.; Izzo, A.A. 2004: Neuroprotective effect of cannabidiol, a non-psychoactive component from Cannabis sativa, on beta-amyloid-induced toxicity in PC12 cells. Journal of Neurochemistry 89(1): 134-141
Han, Y.S.; Chung, I.Y.; Park, J.M.; Yu, J.M. 2005: Neuroprotective effect of citicoline on retinal cell damage induced by kainic acid in rats. Korean Journal of Ophthalmology: Kjo 19(3): 219-226
Thiyagarajan, M.; Sharma, S.S. 2004: Neuroprotective effect of curcumin in middle cerebral artery occlusion induced focal cerebral ischemia in rats. Life Sciences 74(8): 969-985
Bul'on, V.V.; Kuznetsova, N.N.; Selina, E.N.; Kovalenko, A.L.; Alekseeva, L.E.; Sapronov, N.S. 2005: Neuroprotective effect of cytoflavin during compression injury of the spinal cord. Bulletin of Experimental Biology and Medicine 139(4): 394-396
Bul'on, V.V.; Zarubina, I.V.; Kovalenko, A.L.; Alekseeva, L.E.; Sapronov, N.S. 2003: Neuroprotective effect of cytoflavin in closed craniocerebral trauma. Eksperimental'naia i Klinicheskaia Farmakologiia 66(6): 56-58
Tang, Y.; Yu, S.-G.; Luo, S.; Han, T.; Yin, H.-Y. 2006: Neuroprotective effect of electroacupuncture therapy on damaged cholinergic neurons in rats with Alzheimer's disease. Zhong Xi Yi Jie he Xue Bao 4(4): 374-377
Shi, J.; Jiag, Y.; Liu, X. 2004: Neuroprotective effect of erigeron breviscapus (vant) hand-mazz on NMDA-induced retinal neuron injury in the rats. Yan Ke Xue Bao 20(2): 113-117
Kumral, A.; Ozer, E.; Yilmaz, O.; Akhisaroglu, M.; Gokmen, N.; Duman, N.; Ulukus, C.; Genc, S.; Ozkan, H. 2003: Neuroprotective effect of erythropoietin on hypoxic-ischemic brain injury in neonatal rats. Biology of the Neonate 83(3): 224-228
Cao, W.; Rajala, R.V.S.; Li, F.; Anderson, R.E.; Wei, N.; Soliman, C.E.; McGinnis, J.F. 2003: Neuroprotective effect of estrogen upon retinal neurons in vitro. Advances in Experimental Medicine and Biology 533: 395-402
Jiang, S.; Ding, X.-M.; Mao, B.-Y. 2005: Neuroprotective effect of exogenous vascular endothelial growth factor on anoxic rat spinal cord astrocyte and the underlying mechanism. Sichuan da Xue Xue Bao. Yi Xue Ban 36(6): 792-796
Lepeintre, J.-F.; D'Arbigny, P.; Mathé, J.-F.; Vigué, B.; Loubert, G.; Delcour, J.; Kempf, C.; Tadié, M. 2004: Neuroprotective effect of gacyclidine. a multicenter double-blind pilot trial in patients with acute traumatic brain injury. Neuro-Chirurgie 50(2-3 Pt 1: 83-95
Solaroglu, I.; Jadhav, V.; Zhang, J.H. 2007: Neuroprotective effect of granulocyte-colony stimulating factor. Frontiers in Bioscience: a Journal and Virtual Library 12: 712-724
Ostrowski, R.P.; Colohan, A.R.T.; Zhang, J.H. 2006: Neuroprotective effect of hyperbaric oxygen in a rat model of subarachnoid hemorrhage. Acta Neurochirurgica. Suppl 96: 188-193
Wang, X.-Y.; Zhu, C.-L.; Xu, F.-L.; Cheng, X.-Y.; Qiu, L.; Hu, S.-H. 2006: Neuroprotective effect of hypothermia on hypoxic-ischemic brain injury in mice. Zhongguo Dang Dai Er Ke Za Zhi 8(4): 315-318
Zheng, Z.-Q.; Fang, X.-J.; Zhang, Y.; Qiao, J.-T. 2005: Neuroprotective effect of lysophosphatidic acid on AbetaP31-35-induced apoptosis in cultured cortical neurons. Sheng Li Xue Bao: 57(3): 289-294
Kim, Y-Bae.; Oh, S.Hee.; Sok, D-Eun.; Kim, M.Ree. 2004: Neuroprotective effect of maltol against oxidative stress in brain of mice challenged with kainic acid. Nutritional Neuroscience 7(1): 33-39
Tang, Q.; Hu, Y.; Cao, Y. 2006: Neuroprotective effect of melatonin on retinal ganglion cells in rats. Journal of Huazhong University of Science and Technology. Medical Sciences 26(2): 235-237; 253
Kimura, T.; Sato, M.; Nishikawa, T.; Tanaka, M.; Tobe, Y.; Masaki, Y. 2005: Neuroprotective effect of mivazerol, an alpha 2-agonist, after transient forebrain ischemia in rats. Acta Anaesthesiologica Scandinavica 49(8): 1117-1123
Li, Q.; Lu, B.-x.; Wang, X.-y. 2004: Neuroprotective effect of monoamine oxidase monoclonal antibody against vasogenic brain edema in rats. Di 1 Jun Yi da Xue Xue Bao 24(1): 53-56
Shan, Y.; Qin, J.; Chang, X.-z.; Yang, Z.-x. 2004: Neuroprotective effect of naloxone in brain damage caused by repeated febrile seizure. Zhonghua Er Ke Za Zhi 42(4): 260-263
Kakizawa, H.; Matsui, F.; Tokita, Y.; Hirano, K.; Ida, M.; Nakanishi, K.; Watanabe, M.; Sato, Y.; Okumura, A.; Kojima, S.; Oohira, A. 2007: Neuroprotective effect of nipradilol, an NO donor, on hypoxic-ischemic brain injury of neonatal rats. Early Human Development 83(8): 535-540
Iijima, T.; Mishima, T.; Akagawa, K.; Iwao, Y. 2006: Neuroprotective effect of propofol on necrosis and apoptosis following oxygen-glucose deprivation--relationship between mitochondrial membrane potential and mode of death. Brain Research 1099(1): 25-32
Kovalenko, T.M.; Osadchenko, I.O.; Tsupykov, O.M.; Pivneva, T.A.; Shalamaĭ, A.S.; Moĭbenko, O.O.; Skybo, H.H. 2006: Neuroprotective effect of quercetin during experimental brain ischemia. Fiziolohichnyi Zhurnal 52(5): 21-27
Wang, Q.; Chen, S.-y.; Xiong, L.-z.; Jin, W.-l.; Yang, J. 2005: Neuroprotective effect of sodium ferulate on transient focal cerebral ischemia by weakening activation of postsynaptic density-95 in rats. Chinese Journal of Traumatology 8(5): 297-302
Kostanian, I.A.; Zhokhov, S.S.; Storozheva, Z.I.; Proshin, A.T.; Surina, E.A.; Babichenko, I.I.; Sherstnev, V.V.; Lipkin, V.M. 2006: Neuroprotective effect of the hexapeptide HLDF-6 on neurons of rat hippocampus on the model of Alzheimer's disease in vivo and in vitro. Bioorganicheskaia Khimiia 32(4): 399-407
Saito, S.; Ohashi, M.; Naito, A.; Fukaya, Y.; Suzuki, Y.; Araie, M. 2005: Neuroprotective effect of the novel Na+/Ca2+ channel blocker NS-7 on rat retinal ganglion cells. Japanese Journal of Ophthalmology 49(5): 371-376
Sutherland, B.A.; Shaw, O.M.; Clarkson, A.N.; Jackson, D.N.; Sammut, I.A.; Appleton, I. 2005: Neuroprotective effects of (-)-epigallocatechin gallate following hypoxia-ischemia-induced brain damage: novel mechanisms of action. Faseb Journal: Official Publication of the Federation of American Societies for Experimental Biology 19(2): 258-260
Ding-Zhou, L.; Marchand-Verrecchia, C.; Palmier, B.; Croci, N.; Chabrier, P.-E.; Plotkine, M.; Margaill, I. 2003: Neuroprotective effects of (S)-N-[4-[4-[(3,4-Dihydro-6-hydroxy-2,5,7,8-tetramethyl-2H-1-benzopyran-2-yl)carbonyl]-1-piperazinyl]phenyl]-2-thiophenecarboximid-amide (BN 80933), an inhibitor of neuronal nitric-oxide synthase and an antioxidant, in model of transient focal cerebral ischemia in mice. Journal of Pharmacology and Experimental Therapeutics 306(2): 588-594
Wang, X.; Dykens, J.A.; Perez, E.; Liu, R.; Yang, S.; Covey, D.F.; Simpkins, J.W. 2006: Neuroprotective effects of 17beta-estradiol and nonfeminizing estrogens against H2O2 toxicity in human neuroblastoma SK-N-SH cells. Molecular Pharmacology 70(1): 395-404
Jia, R.-z.; Jiang, L.; Qiao, L.-x.; Chen, P.-s. 2003: Neuroprotective effects of Astragulus membranaceus on hypoxia-ischemia brain damage in neonatal rat hippocampus. Zhongguo Zhong Yao Za Zhi 28(12): 1174-1177
Li, X.-M.; Bai, X.-C.; Qin, L.-N.; Huang, H.; Xiao, Z.-J.; Gao, T.-M. 2003: Neuroprotective effects of Buyang Huanwu Decoction on neuronal injury in hippocampus after transient forebrain ischemia in rats. Neuroscience Letters 346(1-2): 29-32
Akgun, S.; Tekeli, A.; Kurtkaya, O.; Civelek, A.; Isbir, S.C.; Ak, K.; Arsan, S.; Sav, A. 2004: Neuroprotective effects of FK-506, L-carnitine and azathioprine on spinal cord ischemia-reperfusion injury. European Journal of Cardio-Thoracic Surgery: Official Journal of the European Association for Cardio-Thoracic Surgery 25(1): 105-110
Pei, D.-S.; Guan, Q.-H.; Sun, Y.-F.; Zhang, Q.-X.; Xu, T.-L.; Zhang, G.-Y. 2005: Neuroprotective effects of GluR6 antisense oligodeoxynucleotides on transient brain ischemia/reperfusion-induced neuronal death in rat hippocampal CA1 region. Journal of Neuroscience Research 82(5): 642-649
Van der Weerd, L.; Lythgoe, M.F.; Badin, R.A.; Valentim, L.M.; Akbar, M.T.; de Belleroche, J.S.; Latchman, D.S.; Gadian, D.G. 2005: Neuroprotective effects of HSP70 overexpression after cerebral ischaemia--an MRi study. Experimental Neurology 195(1): 257-266
Tsuda, K. 2004: Neuroprotective effects of MK-801 and catecholamine release in the central nervous system. Stroke 35(5): E96
Domin, H.; Kajta, M.łg.; Smiałowska, M. 2006: Neuroprotective effects of MTEP, a selective mGluR5 antagonists and neuropeptide y on the kainate-induced toxicity in primary neuronal cultures. Pharmacological Reports: Pr 58(6): 846-858
Cho, Y.; Ueda, T.; Mori, A.; Shimizu, H.; Yozu, R. 2003: Neuroprotective effects of N-methyl-D-aspartate receptor antagonist on aspartate induced neurotoxicity in the spinal cord in vivo. Japanese Journal of Thoracic and Cardiovascular Surgery: Official Publication of the Japanese Association for Thoracic Surgery 51(10): 500-505
Sopala, M.; Danysz, W.; Quack, G. 2002: Neuroprotective effects of NS-7, voltage-gated Na+/Ca2+ channel blocker in a rodent model of transient focal ischaemia. Neurotoxicity Research 4(7-8): 655-661
Zhu, X.-h.; Yang, J.-m.; Gao, T.-M. 2004: Neuroprotective effects of Naoxintong against neuronal injury in hippocampal CA1 region following transient forebrain ischemia in rats. Di 1 Jun Yi da Xue Xue Bao 24(10): 1123-1125
Hsiao, G.; Lee, J.-J.; Chen, Y.-C.; Lin, J.-H.; Shen, M.-Y.; Lin, K.-H.; Chou, D.-S.; Sheu, J.-R. 2007: Neuroprotective effects of PMC, a potent alpha-tocopherol derivative, in brain ischemia-reperfusion: reduced neutrophil activation and anti-oxidant actions. Biochemical Pharmacology 73(5): 682-693
He, Q.; Zhou, H.; Xue, B.; Niu, D.; Wang, X. 2003: Neuroprotective effects of Tripterygium Wilforddi Hook F monomer T10 on glutamate induced PC12 cell line damage and its mechanism. Beijing da Xue Xue Bao. Yi Xue Ban 35(3): 252-255
Iwashita, A.; Yamazaki, S.; Mihara, K.; Hattori, K.; Yamamoto, H.; Ishida, J.; Matsuoka, N.; Mutoh, S. 2004: Neuroprotective effects of a novel poly(ADP-ribose) polymerase-1 inhibitor, 2-[3-[4-(4-chlorophenyl)-1-piperazinyl] propyl]-4(3H)-quinazolinone (FR255595), in an in vitro model of cell death and in mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease. Journal of Pharmacology and Experimental Therapeutics 309(3): 1067-1078
Galaeva, I.P.; Garibova, T.L.; Voronina, T.A.; Seredenin, S.B. 2005: Neuroprotective effects of afobazol in experimental cerebral hemorrhage. Bulletin of Experimental Biology and Medicine 140(5): 535-537
Zhu, M.-Y.; Wang, W.-P.; Bissette, G. 2006: Neuroprotective effects of agmatine against cell damage caused by glucocorticoids in cultured rat hippocampal neurons. Neuroscience 141(4): 2019-2027
Kawaguchi, M.; Furuya, H.; Patel, P.M. 2005: Neuroprotective effects of anesthetic agents. Journal of Anesthesia 19(2): 150-156
Yu, M.-S.; Leung, S.K.-Y.; Lai, S.-W.; Che, C.-M.; Zee, S.-Y.; So, K.-F.; Yuen, W.-H.; Chang, R.C.-C. 2005: Neuroprotective effects of anti-aging oriental medicine Lycium barbarum against beta-amyloid peptide neurotoxicity. Experimental Gerontology 40(8-9): 716-727
Chuang, Y.-C.; Chan, J.Y.H.; Chang, A.Y.W.; Sikorska, M.; Borowy-Borowski, H.; Liou, C.-W.; Chan, S.H.H. 2003: Neuroprotective effects of coenzyme Q10 at rostral ventrolateral medulla against fatality during experimental endotoxemia in the rat. Shock 19(5): 427-432
Milgram, N.W.; Siwak-Tapp, C.T.; Araujo, J.; Head, E. 2006: Neuroprotective effects of cognitive enrichment. Ageing Research Reviews 5(3): 354-369
Sánchez-Ramón, S.; Resino, S.; Bellón Cano, J.é M.; Ramos, J.é T.; Gurbindo, D.; Muñoz-Fernández, A. 2003: Neuroprotective effects of early antiretrovirals in vertical HIV infection. Pediatric Neurology 29(3): 218-221
Yoshida, H.; Yanai, H.; Namiki, Y.; Fukatsu-Sasaki, K.; Furutani, N.; Tada, N. 2006: Neuroprotective effects of edaravone: a novel free radical scavenger in cerebrovascular injury. Cns Drug Reviews 12(1): 9-20
Kajta, M.łg.; Lasoń, W.ła.ła.; Bień, E.; Marszał, M.ł 2002: Neuroprotective effects of estrone on NMDA-induced toxicity in primary cultures of rat cortical neurons are independent of estrogen receptors. Polish Journal of Pharmacology 54(6): 727-729
Rausch, W.-D.; Liu, S.; Gille, G.; Radad, K. 2006: Neuroprotective effects of ginsenosides. Acta Neurobiologiae Experimentalis 66(4): 369-375
Han, T.Ryoon.; Chun, M.Ho.; Jang, D.Hyun.; Kim, K-Soo.; Lim, K.Ho.; Cho, H.Jin. 2007: Neuroprotective effects of growth hormone against hypoxic-ischemic brain injury in neonatal rats: 1H magnetic resonance spectroscopic study. Journal of Korean Medical Science 22(1): 122-126
Zhang, H.Y.; Tang, X.C. 2006: Neuroprotective effects of huperzine A: new therapeutic targets for neurodegenerative disease. Trends in Pharmacological Sciences 27(12): 619-625
Paques, M.W.; Guizzo, R.; Siqueira, R.C.; Silva, A.ôn.R.M.; Cardillo, J.é A.; Scott, I.U.; Flynn, H.W.; Santos, W.F.; Jorge, R. 2006: Neuroprotective effects of intramuscular ketamine in rabbit retinas after pars plana vitrectomy and silicone oil injection. Retina 26(2): 196-201
Yang, Z.-m.; Feng, X.; Sun, B. 2006: Neuroprotective effects of melatonin against hypoxic-ischemic brain damage in neonatal rats. Zhonghua Er Ke Za Zhi 44(6): 467-468
Melcangi, R.C.; Mensah-Nyagan, A.G. 2006: Neuroprotective effects of neuroactive steroids in the spinal cord and peripheral nerves. Journal of Molecular Neuroscience: Mn 28(1): 1-2
Sharma, H.S. 2005: Neuroprotective effects of neurotrophins and melanocortins in spinal cord injury: an experimental study in the rat using pharmacological and morphological approaches. Annals of the new York Academy of Sciences 1053: 407-421
Brewer, K.L.; Hardin, J.S. 2004: Neuroprotective effects of nicotinamide after experimental spinal cord injury. Academic Emergency Medicine: Official Journal of the Society for Academic Emergency Medicine 11(2): 125-130
Copeland, R.L.; Leggett, Y.A.; Kanaan, Y.M.; Taylor, R.E.; Tizabi, Y. 2005: Neuroprotective effects of nicotine against salsolinol-induced cytotoxicity: implications for Parkinson's disease. Neurotoxicity Research 8(3-4): 289-293
Chen, L.-H.; Liu, L.-X.; Yang, Y.-J.; Liu, Y.-S.; Cao, M.-H. 2003: Neuroprotective effects of nimodipine and MK-801 on acute infectious brain edema induced by injection of pertussis bacilli to neocortex of rats. Chinese Journal of Traumatology 6(2): 118-123
Sharma, H.S.; Badgaiyan, R.D.; Alm, P.; Mohanty, S.; Wiklund, L. 2005: Neuroprotective effects of nitric oxide synthase inhibitors in spinal cord injury-induced pathophysiology and motor functions: an experimental study in the rat. Annals of the new York Academy of Sciences 1053: 422-434
He, J.; Xu, H.; Yang, Y.; Zhang, X.; Li, X-Min. 2004: Neuroprotective effects of olanzapine on methamphetamine-induced neurotoxicity are associated with an inhibition of hyperthermia and prevention of Bcl-2 decrease in rats. Brain Research 1018(2): 186-192
Rockenstein, E.; Torrance, M.; Adame, A.; Mante, M.; Bar-on, P.; Rose, J.B.; Crews, L.; Masliah, E. 2007: Neuroprotective effects of regulators of the glycogen synthase kinase-3beta signaling pathway in a transgenic model of Alzheimer's disease are associated with reduced amyloid precursor protein phosphorylation. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 27(8): 1981-1991
Levitskaia, N.G.; Sebentsova, E.A.; Andreeva, L.A.; Alfeeva, L.I.; Kamenskiĭ, A.A.; Miasoedov, N.F. 2002: Neuroprotective effects of semax in MPTP-induced disturbances of brain dopamine system. Rossiiskii Fiziologicheskii Zhurnal Imeni I.M. Sechenova 88(11): 1369-1377
Marrazzo, A.; Caraci, F.; Salinaro, E.T.; Su, T.-P.; Copani, A.; Ronsisvalle, G. 2005: Neuroprotective effects of sigma-1 receptor agonists against beta-amyloid-induced toxicity. Neuroreport 16(11): 1223-1226
Azcoitia, Iñigo.; Moreno, A.; Carrero, P.; Palacios, S.; Garcia-Segura, L.M. 2006: Neuroprotective effects of soy phytoestrogens in the rat brain. Gynecological Endocrinology: the Official Journal of the International Society of Gynecological Endocrinology 22(2): 63-69
Clarkson, A.N.; Liu, H.; Pearson, L.; Kapoor, M.; Harrison, J.C.; Sammut, I.A.; Jackson, D.M.; Appleton, I. 2004: Neuroprotective effects of spermine following hypoxic-ischemic-induced brain damage: a mechanistic study. Faseb Journal: Official Publication of the Federation of American Societies for Experimental Biology 18(10): 1114-1116
Labrande, C.; Velly, L.; Canolle, B.; Guillet, B.; Masmejean, F.; Nieoullon, A.; Pisano, P. 2006: Neuroprotective effects of tacrolimus (FK506) in a model of ischemic cortical cell cultures: role of glutamate uptake and FK506 binding protein 12 kDa. Neuroscience 137(1): 231-239
Makarewicz, D.; Gadamski, R.; Ziembowicz, A.; Kozikowski, A.P.; Wroblewski, J.T.; Lazarewicz, J.W. 2006: Neuroprotective effects of the agonist of metabotropic glutamate receptors ABHxD-i in two animal models of cerebral ischaemia. Resuscitation 68(1): 119-126
Kang, T.H.; Hur, J.Y.; Kim, H.B.; Ryu, J.H.; Kim, S.Y. 2006: Neuroprotective effects of the cyanidin-3-O-beta-d-glucopyranoside isolated from mulberry fruit against cerebral ischemia. Neuroscience Letters 391(3): 122-126
Turner, B.K.; Wakim, J.H.; Secrest, J.; Zachary, R. 2005: Neuroprotective effects of thiopental, propofol, and etomidate. Aana Journal 73(4): 297-302
Pappalardo, A.; Liberto, A.; Patti, F.; Reggio, A. 2004: Neuroprotective effects of topiramate. La Clinica Terapeutica 155(2-3): 75-78
Xerri, C.; Zennou-Azougui, Y.; Coq, J.-O. 2003: Neuroprotective effects on somatotopic maps resulting from piracetam treatment and environmental enrichment after focal cortical injury. Ilar Journal 44(2): 110-124
Iwashita, A.; Muramatsu, Y.; Yamazaki, T.; Muramoto, M.; Kita, Y.; Yamazaki, S.; Mihara, K.; Moriguchi, A.; Matsuoka, N. 2007: Neuroprotective efficacy of the peroxisome proliferator-activated receptor delta-selective agonists in vitro and in vivo. Journal of Pharmacology and Experimental Therapeutics 320(3): 1087-1096
Maruyama, W.; Yi, H.; Takahashi, T.; Shimazu, S.; Ohde, H.; Yoneda, F.; Iwasa, K.; Naoi, M. 2004: Neuroprotective function of R-(-)-1-(benzofuran-2-yl)-2-propylaminopentane, [R-(-)-BPAP], against apoptosis induced by N-methyl(R)salsolinol, an endogenous dopaminergic neurotoxin, in human dopaminergic neuroblastoma SH-SY5Y cells. Life Sciences 75(1): 107-117
Anderzhanova, E.; Saransaari, P.; Oja, S.S. 2006: Neuroprotective mechanisms of taurine in vivo. Advances in Experimental Medicine and Biology 583: 377-387
Toso, L.; Roberson, R.; Abebe, D.; Spong, C.Y. 2007: Neuroprotective peptides prevent some alcohol-induced alteration in gamma-aminobutyric acid A-beta3, which plays a role in cleft lip and palate and learning in fetal alcohol syndrome. American Journal of Obstetrics and Gynecology 196(3): 259.E1-5
Danysz, W.; Parsons, C.G. 2002: Neuroprotective potential of ionotropic glutamate receptor antagonists. Neurotoxicity Research 4(2): 119-126
Malva, J.ão.O.; Santos, S.; Macedo, T. 2004: Neuroprotective properties of Valeriana officinalis extracts. Neurotoxicity Research 6(2): 131-140
Zenina, T.A.; Gavrish, I.V.; Melkumyan, D.S.; Seredenina, T.S.; Seredenin, S.B. 2005: Neuroprotective properties of afobazol in vitro. Bulletin of Experimental Biology and Medicine 140(2): 194-196
Rauhala, P.; Andoh, T.; Chiueh, C.C. 2005: Neuroprotective properties of nitric oxide and S-nitrosoglutathione. Toxicology and Applied Pharmacology 207(2): 91-95
Lun'shina, E.V.; Gan'shina, T.S.; Makarova, L.M.; Pogorelyĭ, V.E.; Mirzoian, R.S. 2003: Neuroprotective properties of pyroglutamic acid in combination with pyrrolidone. Eksperimental'naia i Klinicheskaia Farmakologiia 66(1): 20-22
Sokołowska, P.; Dejda, A.; Nowak, J.Z. 2004: Neuroprotective role of PACAP, VIP, and PHi in the central nervous system. Postepy Higieny i Medycyny Doswiadczalnej 58: 416-427
Trendelenburg, G.; Dirnagl, U. 2005: Neuroprotective role of astrocytes in cerebral ischemia: focus on ischemic preconditioning. Glia 50(4): 307-320
Nakase, T.; Fushiki, S.; Söhl, G.; Theis, M.; Willecke, K.; Naus, C.C.G. 2003: Neuroprotective role of astrocytic gap junctions in ischemic stroke. Cell Communication and Adhesion 10(4-6): 413-417
Li, F.C.H.; Tseng, H.P.; Chang, A.Y.W. 2005: Neuroprotective role of coenzyme Q10 against dysfunction of mitochondrial respiratory chain at rostral ventrolateral medulla during fatal mevinphos intoxication in the rat. Annals of the new York Academy of Sciences 1042: 195-202
Gupta, Y.K.; Gupta, M.; Kohli, K. 2003: Neuroprotective role of melatonin in oxidative stress vulnerable brain. Indian Journal of Physiology and Pharmacology 47(4): 373-386
Saito, A.; Tominaga, T.; Chan, P.H. 2005: Neuroprotective role of neurotrophins: relationship between nerve growth factor and apoptotic cell survival pathway after cerebral ischemia. Current Atherosclerosis Reports 7(4): 268-273
Dou, H.; Kingsley, J.D.; Mosley, R.L.; Gelbard, H.A.; Gendelman, H.E. 2004: Neuroprotective strategies for HIV-1 associated dementia. Neurotoxicity Research 6(7-8): 503-521
Meissner, W.; Hill, M.P.; Tison, F.ço.; Gross, C.E.; Bezard, E. 2004: Neuroprotective strategies for Parkinson's disease: conceptual limits of animal models and clinical trials. Trends in Pharmacological Sciences 25(5): 249-253
Longo, F.M.; Massa, S.M. 2004: Neuroprotective strategies in Alzheimer's disease. Neurorx: the Journal of the American Society for Experimental Neurotherapeutics 1(1): 117-127
Chiueh, C.C.; Andoh, T.; Lai, A.R.; Lai, E.; Krishna, G. 2000: Neuroprotective strategies in Parkinson's disease: protection against progressive nigral damage induced by free radicals. Neurotoxicity Research 2(2-3): 293-310
Schiff, J.D.; Mulhall, J.P. 2005: Neuroprotective strategies in radical prostatectomy. Bju International 95(1): 11-14
Huber, A.; Stuchbury, G.; Bürkle, A.; Burnell, J.; Münch, G. 2006: Neuroprotective therapies for Alzheimer's disease. Current Pharmaceutical Design 12(6): 705-717
Turchan, J.; Sacktor, N.; Wojna, V.; Conant, K.; Nath, A. 2003: Neuroprotective therapy for HIV dementia. Current HIV Research 1(4): 373-383
Chen, S.; Le, W. 2006: Neuroprotective therapy in Parkinson disease. American Journal of Therapeutics 13(5): 445-457
Olanow, C.W.; Jankovic, J. 2005: Neuroprotective therapy in Parkinson's disease and motor complications: a search for a pathogenesis-targeted, disease-modifying strategy. Movement Disorders: Official Journal of the Movement Disorder Society 20(Suppl 11): S3-10
Golovacheva, M.O. 2006: Neuroprotective treatment of patients with normal tension glaucoma. Georgian Medical News 131: 37-40
Kyriazis, M. 2003: Neuroprotective, anti-apoptotic effects of apomorphine. Journal of Anti-Aging Medicine 6(1): 21-28
Ottens, A.K.; Kobeissy, F.H.; Golden, E.C.; Zhang, Z.; Haskins, W.E.; Chen, S-Shing.; Hayes, R.L.; Wang, K.K.W.; Denslow, N.D. 2006: Neuroproteomics in neurotrauma. Mass Spectrometry Reviews 25(3): 380-408
Uys, J.D.K.; Stein, D.J.; Daniels, W.M.U. 2006: Neuroproteomics: relevance to anxiety disorders. Current Psychiatry Reports 8(4): 286-290
Rasmussen, J.E. 1965: Neuropsychiatric Assessment of Naval Personnel. Military Medicine 130: 73-78
Drath, A. 1963: Neuropsychiatric Disorders as Sequelae of Fetal and Obstetric Trauma. Revue de Neuropsychiatrie Infantile et d'Hygiene Mentale de l'Enfance 11: 321-329
Karpati, G.; Frame, B. 1964: Neuropsychiatric Disorders in Primary Hyperparathyroidism. Clinical Analysis with Review of the Literature. Archives of Neurology 10: 387-397
Kaminska, M.; Serbenska Panczyj, Z. 1963: Neuropsychiatric Disorders in the Treatment of Pulmonary Tuberculosis with Cycloserine. Gruzlica 31: 875-881
Harada, M. 1964: Neuropsychiatric Disturbances Due to Organic Mercury Poisoning during the Prenatal Period. Seishin Shinkeigaku Zasshi 66: 429-468
Boada, M.; Tárraga, L.; Modinos, G.; López, O.L.; Cummings, J.L. 2005: Neuropsychiatric Inventory-Nursing Home version (NPI-NH): Spanish validation. Neurologia 20(10): 665-673
Iranyi, K.; Iranyi, J.; Orovecz, B.; Somogyi, E. 1964: Neuropsychiatric Phenomena Following Lightning-Stroke Accidents. Psychiatrie Neurologie und Medizinische Psychologie 16: 310-315
Raison, C.L.; Demetrashvili, M.; Capuron, L.; Miller, A.H. 2005: Neuropsychiatric adverse effects of interferon-alpha: recognition and management. Cns Drugs 19(2): 105-123
Allavena, C.; Le Moal, G.; Michau, C.; Chiffoleau, A.; Raffi, Fçois. 2006: Neuropsychiatric adverse events after switching from an antiretroviral regimen containing efavirenz without tenofovir to an efavirenz regimen containing tenofovir: a report of nine cases. Antiviral Therapy 11(2): 263-265
Zec, N. 1951: Neuropsychiatric affections and endemic syphilis in Bosnia and Herzegovina. Acta Medica Iugoslavica 5(1-2): 176-200
Herning, R.I.; Better, W.; Tate, K.; Cadet, J.L. 2005: Neuropsychiatric alterations in MDMA users: preliminary findings. Annals of the new York Academy of Sciences 1053: 20-27
Ortiz, F.; Fitten, L.J.; Cummings, J.L.; Hwang, S.; Fonseca, M. 2006: Neuropsychiatric and behavioral symptoms in a community sample of Hispanics with Alzheimer's disease. American Journal of Alzheimer's Disease and other Dementias 21(4): 263-273
Dotzenrath, C.M.E.; Kaetsch, A.K.; Pfingsten, H.; Cupisti, K.; Weyerbrock, N.; Vossough, A.; Verde, P.E.; Ohmann, C. 2006: Neuropsychiatric and cognitive changes after surgery for primary hyperparathyroidism. World Journal of Surgery 30(5): 680-685
Ephraty, L.; Porat, O.; Israeli, D.; Cohen, O.S.; Tunkel, O.; Yael, S.; Hatano, Y.; Hattori, N.; Hassin-Baer, S. 2007: Neuropsychiatric and cognitive features in autosomal-recessive early parkinsonism due to PINK1 mutations. Movement Disorders: Official Journal of the Movement Disorder Society 22(4): 566-569
Faure, J.; Morin, G.; Dutertre, F. 1953: Neuropsychiatric and endocrine aspects in temporal epilepsy. Revue Neurologique (Paris) 88(5): 382-384
Bortz, J.J. 2003: Neuropsychiatric and memory issues in epilepsy. Mayo Clinic Proceedings 78(6): 781-787
Benda, C.E. 1957: Neuropsychiatric and neuropathological aspects of prematurity. Annales Paediatriae Fenniae 3(2): 109-117
Trethowan, W.H.; Cobb, S. 1952: Neuropsychiatric aspects of Cushing's syndrome. A.M.A. Archives of Neurology and Psychiatry 67(3): 283-309
Tost, H.; Schmitt, A.; Brassen, S.; Wendt, C.S.; Braus, D.F. 2004: Neuropsychiatric aspects of Huntington chorea. Presentation of 2 cases and review of the literature. Der Nervenarzt 75(3): 258-266
Marsh, L.; Berk, A. 2003: Neuropsychiatric aspects of Parkinson's disease: recent advances. Current Psychiatry Reports 5(1): 68-76
Gonzalez Mas, R. 1953: Neuropsychiatric aspects of art in ancient Egypt. Medicina 21(4 Part 2): 239-243
Alonso Fernandez, F. 1955: Neuropsychiatric aspects of chronic manganese poisoning. Medicina 23(8): 409-412
Martin, F. 1958: Neuropsychiatric aspects of deficiency manifestations associated with digestive and neuro-endocrine disorders. IV. Lesions of the nervous system in a case of cachexia due to starvation. Psychiatria et Neurologia 135(4-5): 247-260
Gigineĭshvili, D.A.; Shakarishvili, R.R. 2006: Neuropsychiatric aspects of diagnostics of nonepileptic seizures. Georgian Medical News 131: 52-55
Ceh, G.; Crepinko, I.; Skrabalo, Z. 1964: Neuropsychiatric aspects of endemic cretinism in the Koprivnica District. Neuropsihijatrija 12(1-4): 77-82
Dunn, D.W. 2003: Neuropsychiatric aspects of epilepsy in children. Epilepsy and Behavior: E&b 4(2): 101-106
Saucier, J. 1955: Neuropsychiatric aspects of genital deficiencies in man; impotence. L'Union Medicale du Canada 84(9): 1012-1016
Delmar, A. 1957: Neuropsychiatric aspects of hypertension. La Semana Medica 111(Suppl 21): 716-718 Passim
Davis, J.D.; Tremont, G. 2007: Neuropsychiatric aspects of hypothyroidism and treatment reversibility. Minerva Endocrinologica 32(1): 49-65
Rosenthal, M.J. 1953: Neuropsychiatric aspects of infantile eczema; special reference to the role of cutaneous pain receptors. A.M.A. Archives of Neurology and Psychiatry 70(4): 428-451
Peterlin, B.L.; Ward, T.N. 2005: Neuropsychiatric aspects of migraine. Current Psychiatry Reports 7(5): 371-375
Kinsey, J.L. 1960: Neuropsychiatric aspects of space and depth medicine. Diseases of the Nervous System 21(2)suppl: 112-115
Delmar, A. 1957: Neuropsychiatric aspects of the sclerohypertensive vascular syndrome. El Dia Medico 29(14): 337; Passim
Pelaz, E. 1953: Neuropsychiatric aspects of tuberculous meningitis. Medicina 21(1-2): 93-104
Morales, J.L.; Sanmartin, A. 1955: Neuropsychiatric assistance work in the provincial departments of national infant and maternal health. Acta Pediatrica Espanola 13(150): 421-423
Freeman, T.; Roca, V.; Guggenheim, F.; Kimbrell, T.; Griffin, W.S.T. 2005: Neuropsychiatric associations of apolipoprotein E alleles in subjects with combat-related posttraumatic stress disorder. Journal of Neuropsychiatry and Clinical Neurosciences 17(4): 541-543
Kitabayashi, Y.; Narumoto, J.; Shibata, K.; Ueda, H.; Fukui, K. 2007: Neuropsychiatric background of alcohol hallucinosis: a SPECT study. Journal of Neuropsychiatry and Clinical Neurosciences 19(1): 85
Aftab, O.; Naqvi, H. 2005: Neuropsychiatric care in epilepsy surgery. Jpma. Journal of the Pakistan Medical Association 55(5): 224
Feigin, S.L. 1953: Neuropsychiatric casualties as a result of combat involving Hill 266 ("Old Baldy"). Medical Bulletin of the U. S. Army Far East 1(8): 134-136
Notman, R. 1954: Neuropsychiatric casualties, World War Ii. Treatment Services Bulletin. Canada. DePartment of Veterans' Affairs 9(5): 245-266
Nevzorova, T.A. 1958: Neuropsychiatric changes during cortisone and ACTH therapy. Klinicheskaia Meditsina 36(9): 17-24
Corcoran, C.P. 2003: Neuropsychiatric changes in HIV/hepatitis C coinfected patients undergoing interferon therapy. Journal of the Association of Nurses in Aids Care: Janac 14(5 Suppl): 80s-86s
Nevzorova, T.A.; Degtiareva, V.M.; Lebedeva, R.N. 1960: Neuropsychiatric changes in patients subjected to surgery in rheumatic heart defect. Sovetskaia Meditsina 24: 56-67
Drobinskii, I.R. 1959: Neuropsychiatric changes in rickettsial infection transmitted by Gamasidae (rickettsiosis D). Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 59(3): 291-294
Czech, Bław.; Kucewicz, E.; Frank, M. 2003: Neuropsychiatric complication after surgical procedures--literature review. Wiadomosci Lekarskie 56(11-12): 556-559
Nagai, M.; Nomoto, M. 2004: Neuropsychiatric complications associated with digestive system agents. Nihon Rinsho. Japanese Journal of Clinical Medicine 62 Suppl: 498-502
Andersen, E. 1961: Neuropsychiatric complications in diabetes mellitus. Ugeskrift for Laeger 123: 608-613
Levi-Valensi, A.; Porot, M.; Leonardon, P.; Migueres, J.; Dalet, R. 1958: Neuropsychiatric complications occurring in tuberculotics treated with cycloserine. La Presse Medicale 66(38): 849-851
Cespedes, M.S.; Aberg, J.A. 2006: Neuropsychiatric complications of antiretroviral therapy. Drug Safety 29(10): 865-874
Levi-Valensi, A.; Porot, M.; Leonardon, P.; Dalet, R.; Migueres, J. 1957: Neuropsychiatric complications of cycloserine therapy of tuberculosis. Annales Medico-Psychologiques 115(5): 899-923
Garello, L.; Mastropaolo, C. 1961: Neuropsychiatric complications of diabetes mellitus. Clinico-pathogenetic considerations apropos of 50 cases. Minerva Medica 52: 1301-1308
Burn, D.J.; Tröster, A.I. 2004: Neuropsychiatric complications of medical and surgical therapies for Parkinson's disease. Journal of Geriatric Psychiatry and Neurology 17(3): 172-180
Read, A.E.; Laidlaw, J.; Sherlock, S. 1961: Neuropsychiatric complications of portacaval anastomosis. Lancet 1(7184): 961-963
Hugonnier, M.R.; Thevenin, L. 1955: Neuropsychiatric complications of strabismus in children; preliminary note. Bulletin des Societes d'Ophtalmologie de France 1955(6): 427-431
Boittelle, G.; Boittelle-Lentulo, C. 1950: Neuropsychiatric complications of typhoid treated with chloromycetin. Strasbourg Medical 1(Suppl. 1): 5-7
Boittelle, G.; Boittelle-Lentulo, C.; Hourcard, J.D.; Serrier, J. 1950: Neuropsychiatric complications of typhoidal infections treated with chloromycetin. Annales Medico-Psychologiques 108(2 Part 2): 216-218
Leibowitz, S.; Gorman, W.F. 1952: Neuropsychiatric complications of viral hepatitis. New England Journal of Medicine 246(24): 932-937
Bartstra, H.K.G.; Pesman, J. 1950: Neuropsychiatric complications with "Italian influenza"; a report. Folia Psychiatrica Neurologica et Neurochirurgica Neerlandica 53(6): 771-782
Weisz, S. 1957: Neuropsychiatric conditions of interest in the later years. Southern Medical Journal 50(2): 241-244
Jorge, R.E. 2005: Neuropsychiatric consequences of traumatic brain injury: a review of recent findings. Current Opinion in Psychiatry 18(3): 289-299
Bailey, K.G. 1955: Neuropsychiatric considerations peculiar to the aged. Journal of the American Osteopathic Association 55(3): 220-222
Katila, O. 1958: Neuropsychiatric consultations. Suomen Laakarilehti. Finlands Lakartidning 13(30): 1465-1472
Gottschick, J. 1950: Neuropsychiatric disease among German prisoners of war in the United States in the light of statistics. Archiv für Psychiatrie und Nervenkrankheiten Vereinigt Mit Zeitschrift für die Gesamte Neurologie und Psychiatrie 185(4): 491-510
Orgaz, J. 1954: Neuropsychiatric diseases as seen by a general practitioner. El Dia Medico 26(52): 1401-1405
Naquet, R.; Resende, J.; Brouillet, F.; Soulayrol, R. 1958: Neuropsychiatric disorders and EEG changes during cycloserine therapy of pulmonary tuberculosis. Annales Medico-Psychologiques 116 Vol 1(3): 462-472
Fujimori, S.; Yoneda, Y. 2004: Neuropsychiatric disorders and GABA. Nihon Shinkei Seishin Yakurigaku Zasshi 24(5): 265-271
Prick, J.J. 1957: Neuropsychiatric disorders and pathobiological conditioning. Nederlands Tijdschrift Voor Geneeskunde 101(24): 1105-1110
Fernández Ibieta, M.; Ramos Amador, J.T.; Auñón Martínc, I.; Marín, M.A.; González Tomé, M.I.; Simón de Las Heras, R. 2005: Neuropsychiatric disorders associated with streptococci: a case report. Anales de Pediatria 62(5): 475-478
Levitt Katz, L.E.; Swami, S.; Abraham, Máire.; Murphy, K.M.; Jawad, A.F.; McKnight-Menci, H.; Berkowitz, R. 2005: Neuropsychiatric disorders at the presentation of type 2 diabetes mellitus in children. Pediatric Diabetes 6(2): 84-89
Longman, J.; Valente, M.I. 1957: Neuropsychiatric disorders caused by bilateral lesions of the temporal lobe: Klüver-Bucy syndrome. Arquivos de Neuro-Psiquiatria 15(1): 46-57
Chemerinski, E.; Levine, S.R. 2006: Neuropsychiatric disorders following vascular brain injury. Mount Sinai Journal of Medicine new York 73(7): 1006-1014
Czarnecki, M.; Inglot, M.łg.; Małyszczak, K.; Rymer, W.; Jańczak, G.; Pawłowski, T.; Gładysz, A. 2005: Neuropsychiatric disorders in HCV-infected people--own observations. Przeglad Epidemiologiczny 59(2): 431-438
Joaki, E. 1957: Neuropsychiatric disorders in hyperthyroidism. Gazette Medicale de France 64(3): 251-252 Passim
Egorova, N.I. 1960: Neuropsychiatric disorders in hypotension. Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 60: 1592-1593
Desclaux, P.; Soulairac, A.; Morlon, C. 1951: Neuropsychiatric disorders in the child of a malarial mother. Archives Francaises de Pediatrie 8(3): 318-320
Matsuoka, M.; Igisu, H. 2004: Neuropsychiatric disorders induced by exposure to metals. Nihon Rinsho. Japanese Journal of Clinical Medicine 62 Suppl: 503-506
Puri, B.K. 2006: Neuropsychiatric disorders presenting with antisocial behaviour. International Journal of Clinical Practice 60(7): 760-761
Rodrigues, A.C.T.; Dalgalarrondo, P. 2003: Neuropsychiatric disturbances in Wilson's disease and use of electroconvulsive therapy: case report. Arquivos de Neuro-Psiquiatria 61(3b): 876-880
Keller, S.; Frishman, W.H. 2003: Neuropsychiatric effects of cardiovascular drug therapy. Cardiology in Review 11(2): 73-93
Nnadi, C.U.; Mimiko, O.A.; McCurtis, H.L.; Cadet, J.L. 2005: Neuropsychiatric effects of cocaine use disorders. Journal of the National Medical Association 97(11): 1504-1515
Dawson, S.; Woods, C. 2005: Neuropsychiatric effects of efavirenz: delayed onset. International Journal of Std and Aids 16(11): 769-770
Hugonnier, R.; Thevenin, L. 1955: Neuropsychiatric elements of strabismus in children; preliminary note. Pediatrie 10(7): 753-756
Balint, I.; Varga, B.; Hodos, T. 1962: Neuropsychiatric ex-mination of confectionery workers employed on assembly lines. Ideggyogyaszati Szemle 15: 39-45
Flugel, F. 1955: Neuropsychiatric experience with the effects of rauwolfia alkaloids reserpin (serpasil). Medizinische Klinik 50(13): 509-510
Fladung, G. 1960: Neuropsychiatric experiences with Goe 186-W1597 in the treatment of geriatric diseases. Die Medizinische Welt 18: 1009-1012
Geda, Y.E.; Boeve, B.F.; Negash, S.; Graff-Radford, N.R.; Knopman, D.S.; Parisi, J.E.; Dickson, D.W.; Petersen, R.C. 2007: Neuropsychiatric features in 36 pathologically confirmed cases of corticobasal degeneration. Journal of Neuropsychiatry and Clinical Neurosciences 19(1): 77-80
Borchers, A.T.; Aoki, C.A.; Naguwa, S.M.; Keen, C.L.; Shoenfeld, Y.; Gershwin, M.E. 2005: Neuropsychiatric features of systemic lupus erythematosus. Autoimmunity Reviews 4(6): 329-344
Scheid, R.; Voltz, R.; Guthke, T.; Bauer, J.; Sammler, D.; von Cramon, D.Y. 2003: Neuropsychiatric findings in anti-Ma2-positive paraneoplastic limbic encephalitis. Neurology 61(8): 1159-1161
Bredemann, W. 1959: Neuropsychiatric findings in polycythemia vera rubra. Arztliche Wochenschrift 14(15): 285-288
Briegel, W. 2006: Neuropsychiatric findings of Möbius sequence -- a review. Clinical Genetics 70(2): 91-97
Wagner, R.H. 1953: Neuropsychiatric hazards under Arctic conditions. Medical Bulletin of the U. S. Army Europe. United States. Army Europe. Medical Division 10(3): 55-58
Zeltzerman, I. 1951: Neuropsychiatric hospital, Veterans Administration Center, Togus, Maine. Journal of the Maine Medical Association 42(7): 220-222
Hill, K.P.; Lukonis, C.J.; Korson, M.S.; Weinstein, C.; Thall, M.; Schwartz, J.T. 2004: Neuropsychiatric illness in a patient with cobalamin G disease, an inherited disorder of vitamin B12 metabolism. Harvard Review of Psychiatry 12(2): 116-122
Bret, J.; Kohler, C. 1956: Neuropsychiatric incidences of congenital heart diseases in child. Pediatrie 11(1): 59-68
Arbuse, D.I.; Schechtman, J. 1950: Neuropsychiatric indications for therapeutic abortion. American Practitioner and Digest of Treatment 1(10): 1069-1075
Ward, C.D. 2003: Neuropsychiatric interpretations of postencephalitic movement disorders. Movement Disorders: Official Journal of the Movement Disorder Society 18(6): 623-630
de Jonghe, J.F.M.; Kat, M.G.; Kalisvaart, C.J.; Boelaarts, L. 2003: Neuropsychiatric inventory questionnaire (NPI-Q): A validity study of the Dutch form. Tijdschrift Voor Gerontologie en Geriatrie 34(2): 74-77
Fuh, J-Ling.; Lam, L.; Hirono, N.; Senanarong, V.; Cummings, J.L. 2006: Neuropsychiatric inventory workshop: behavioral and psychologic symptoms of dementia in Asia. Alzheimer Disease and Associated Disorders 20(4): 314-317
Weiner, S.M.; Otte, A.; Uhl, M.; Brink, I.; Schumacher, M.; Peter, H.H. 2003: Neuropsychiatric involvement in systemic lupus erythematosus. Part 2: diagnostic and therapy. Medizinische Klinik 98(2): 79-90
Hanly, J.G. 2005: Neuropsychiatric lupus. Rheumatic Diseases Clinics of North America 31(2): 273-98 Vi
Rasić, S.; Dzemidzić, J.; Srna, A.; Aganović, K.; Rebić, D.; Muslimović, A. 2005: Neuropsychiatric lupus and lupus nephritis as a clinical manifestations of systemic lupus erythematosus. Medicinski Arhiv 59(6): 393-395
Vadacca, M.; Buzzulini, F.; Rigon, A.; Coppolino, G.; Palma Modoni, A.; Massa, R.; Afeltra, A. 2006: Neuropsychiatric lupus erythematosus. Reumatismo 58(3): 177-186
Guyotat, J.; Routier, J. 1957: Neuropsychiatric manifestations during the course of treatment with cycloserine. La Semaine des Hopitaux: Organe Fonde Par l'Association d'Enseignement Medical des Hopitaux de Paris 33(24): 1543-1545
Kasitanon, N.; Louthrenoo, W.; Piyasirisilp, S.; Sukitawu, W.; Wichainun, R. 2002: Neuropsychiatric manifestations in Thai patients with systemic lupus erythematosus. Asian Pacific Journal of Allergy and Immunology 20(3): 179-185
Susic, Z.; Ribaric, V.; Ledic, P. 1950: Neuropsychiatric manifestations in brucellosis. Lijecnicki Vjesnik 72(6-7): 224-228
Zhou, H.-q.; Leng, X.-m.; Zhang, F.-c. 2006: Neuropsychiatric manifestations in systemic lupus erythematosus and the treatment of intrathecal methotrexate plus dexamethasone. Zhonghua Yi Xue Za Zhi 86(11): 771-774
Neveu, P.; Boyer, R. 1952: Neuropsychiatric manifestations of ascariasis. Annales Medico-Psychologiques 110(1 Part 2): 201-204
Lapresle, J. 1962: Neuropsychiatric manifestations of disseminated lupus erythematosus. La Semaine des Hopitaux: Organe Fonde Par l'Association d'Enseignement Medical des Hopitaux de Paris 38: 35-39
Pinkston, J.B.; Alekseeva, N. 2006: Neuropsychiatric manifestations of multiple sclerosis. Neurological Research 28(3): 284-290
Khan, A.Y.; Kalimuddin, M.N.; Gorman, J.M. 2007: Neuropsychiatric manifestations of phenytoin toxicity in an elderly patient. Journal of Psychiatric Practice 13(1): 49-54
Gallais, P.; Cardaire, G.; Planques, L.; Pruvost, A.; Cros, R.; Nabholtz, M. 1952: Neuropsychiatric manifestations of sickle cell anemia; a mental form in a Negro; first French neuropsychiatric case report. Bulletin de la Societe de Pathologie Exotique et de Ses Filiales 45(1): 103-112
Bruns, A.; Meyer, O. 2006: Neuropsychiatric manifestations of systemic lupus erythematosus. Joint Bone Spine 73(6): 639-645
Robert, M.; Sunitha, R.; Thulaseedharan, N.K. 2006: Neuropsychiatric manifestations systemic lupus erythematosus: a study from South India. Neurology India 54(1): 75-77
Walker, K.G.; Lawrenson, J.; Wilmshurst, J.M. 2005: Neuropsychiatric movement disorders following streptococcal infection. Developmental Medicine and Child Neurology 47(11): 771-775
Lambo, T.A. 1956: Neuropsychiatric observations in the western region of Nigeria. British Medical Journal 2(5006): 1388-1394
Bargagna, S.; Astrea, G.; Perelli, V.; Rafanelli, V. 2006: Neuropsychiatric outcome in patients with congenital hypothyroidism precautiously treated: Risk factors analysis in a group of patients from Tuscany. Minerva Pediatrica 58(3): 279-287
Wilmer, H.A.; Scammon, R. 1954: Neuropsychiatric patients reported cured at St. Bartholomew's Hospital in the twelfth century; selected cases from the book of the foundation of St. Bartholomew's Church in London. Journal of Nervous and Mental Disease 119(1): 1-22
Bishop, J.R.; Ellingrod, V.L. 2004: Neuropsychiatric pharmacogenetics: moving toward a comprehensive understanding of predicting risks and response. Pharmacogenomics 5(5): 463-477
Roffman, J.L.; Eisenberg, T.; Stern, T.A. 2006: Neuropsychiatric phenomena associated with movement disorders. Primary Care Companion to the Journal of Clinical Psychiatry 8(1): 39-42
Wallace, F.D. 1957: Neuropsychiatric photography. Journal of the Biological Photographic Association 25(1-2): 96-97
Sole Sagarra, J. 1952: Neuropsychiatric pictures in tuberculous meningitis treated with antibiotics. Clinica y Laboratorio 53(310): 36-38
Van Gorp, W.G.; Rabkin, J.G.; Ferrando, S.J.; Mintz, J.; Ryan, E.; Borkowski, T.; McElhiney, M. 2007: Neuropsychiatric predictors of return to work in HIV/AIDS. Journal of the International Neuropsychological Society: Jins 13(1): 80-89
Lehrer, G.M.; Levitt, M.F. 1960: Neuropsychiatric presentation of hypercalcemia. Journal of the Mount Sinai Hospital new York 27: 10-18
Cantu Garza, F. 1952: Neuropsychiatric problems in the army. Boletin de Sanidad Militar 5(45): 28-44
Asato, M.R.; Hardan, A.Y. 2004: Neuropsychiatric problems in tuberous sclerosis complex. Journal of Child Neurology 19(4): 241-249
De Araujo Filho, G.M.; Pascalicchio, T.F.; Lin, K.; Sousa, P.íc.S.; Yacubian, E.M.T. 2006: Neuropsychiatric profiles of patients with juvenile myoclonic epilepsy treated with valproate or topiramate. Epilepsy and Behavior: E&b 8(3): 606-609
Schachter, M.; Cotte, S. 1950: Neuropsychiatric prognosis of a group of congenital syphilitic children. Revista Medica de Cordoba 38(10): 447-450
Murphy, J.B. 1962: Neuropsychiatric progress reports in corrective therapy. Journal of the Association for Physical and Mental Rehabilitation 16: 89-92
Soler Palacin, P.; Aramburo, A.; Moraga, F.A.; Cabañas, M.J.; Figueras, C.ó 2006: Neuropsychiatric reaction induced by abacavir in a pediatric human immunodeficiency virus-infected patient. Pediatric Infectious Disease Journal 25(4): 382
Passanisi, I.; Rossi, M.; Battisti, A. 1963: Neuropsychiatric report on general semeiology and humoral semeiology of old age. Organ semeiology. Considerations on initial neurological and psychiatric symptomatology of senescence. Giornale di Gerontologia 11: 181-192
Magri, R.; Giannelli, A. 1956: Neuropsychiatric sequelae in epidemic encephalitis: cataplegia, dissociative syndrome, peduncular hallucinosis and parkinsonism. Rivista di Patologia Nervosa e Mentale 77(3): 737-748
Ng, B.-Y.; Lim, C.C.T.; Yeoh, A.; Lee, W.L. 2004: Neuropsychiatric sequelae of Nipah virus encephalitis. Journal of Neuropsychiatry and Clinical Neurosciences 16(4): 500-504
Kral, V.A. 1951: Neuropsychiatric sequelae of cardiac arrest during spinal anaesthesia. Canadian Medical Association Journal 64(2): 138-142
Knobloch, H.; Rider, R.; Harper, P.; Pasamanick, B. 1956: Neuropsychiatric sequelae of prematurity; a longitudinal study. Journal of the American Medical Association 161(7): 581-585
Kramer, W.; Agema, R. 1961: Neuropsychiatric sequelae of toxicosis in infancy. Acta Neurologica Scandinavica 37(3): 231-241
Bourrat, L.; Guyotat, J.; Cotte; Jouvet; Grandmottet 1955: Neuropsychiatric sequels in adults of neurological complications of whooping cough. Pediatrie 10(4): 443-452
Bourrat, L.; Guyotat, J.; Jouvet; Grandmottet 1954: Neuropsychiatric sequels in adults of the nervous complications of whooping cough. Journal de Medecine de Lyon 35(838): 939-946
Welner, J. 1955: Neuropsychiatric sequels of cardiac arrest under anesthesia. Nordisk Medicin 54(42): 1596-1600
Bauza, C.A.; Solovey, G. 1950: Neuropsychiatric sequels of purulent meningitis; study of children of first infancy using the developmental standards of Gesell. Archivos de Pediatria del Uruguay 21(6): 453-464
Bauza, C.A.; Solovey, G. 1950: Neuropsychiatric sequels of purulent meningitis; study of infants by means of Gesell's norms of development. Archivos de Pediatria del Uruguay 21(5): 340-355 Contd
Kronja, T. 1957: Neuropsychiatric services in an army corps area in Yugoslavia and the role of military physicians. Vojnosanitetski Pregled 14(7-8): 387-392
Bonasera-Vizzini, G. 1953: Neuropsychiatric services of O.N.M.I.: etio-pathogenetic, clinical and prophylactic aspects. Sicilia Sanitaria 6(9): 679-689
Hauser, P. 2004: Neuropsychiatric side effects of HCV therapy and their treatment: focus on IFN alpha-induced depression. Gastroenterology Clinics of North America 33(1 Suppl): S35-S50
Van Gool, A.R.; Kruit, W.H.J.; Engels, F.K.; Stoter, G.; Bannink, M.; Eggermont, A.M.M. 2003: Neuropsychiatric side effects of interferon-alfa therapy. Pharmacy World and Science: Pws 25(1): 11-20
Lyketsos, C.G. 2007: Neuropsychiatric symptoms (behavioral and psychological symptoms of dementia) and the development of dementia treatments. International Psychogeriatrics 19(3): 409-420
Tran, P.; Schmidt, K.; Gallo, J.; Tuppo, E.; Scheinthal, S.; Chopra, A.; Libon, D.J. 2006: Neuropsychiatric symptoms and medical illness in patients with dementia: an exploratory study. Journal of the American Osteopathic Association 106(7): 412-414
Shin, I.-S.; Carter, M.; Masterman, D.; Fairbanks, L.; Cummings, J.L. 2005: Neuropsychiatric symptoms and quality of life in Alzheimer disease. American Journal of Geriatric Psychiatry: Official Journal of the American Association for Geriatric Psychiatry 13(6): 469-474
Murai, Z.; Baran, B.; Tolna, J.; Szily, E.; Gazdag, Gábor. 2005: Neuropsychiatric symptoms caused by mefloquine (report of several cases). Orvosi Hetilap 146(3): 133-136
Tatsch, M.F.; Bottino, C.ás.M.d.C.; Azevedo, D.ís.; Hototian, S.ér.R.; Moscoso, M.A.ôn.; Folquitto, J.C.; Scalco, A.éi.Z.; Louzã, M.R. 2006: Neuropsychiatric symptoms in Alzheimer disease and cognitively impaired, nondemented elderly from a community-based sample in Brazil: prevalence and relationship with dementia severity. American Journal of Geriatric Psychiatry: Official Journal of the American Association for Geriatric Psychiatry 14(5): 438-445
Brage, D. 1957: Neuropsychiatric symptoms in Casal's disease; sporadic latent forms in non-deficient people. Prensa Medica Argentina 44(39): 2956-2964
Hinton, L.; Haan, M.; Geller, S.; Mungas, D. 2003: Neuropsychiatric symptoms in Latino elders with dementia or cognitive impairment without dementia and factors that modify their association with caregiver depression. Gerontologist 43(5): 669-677
Ueda, M.; Uchino, M. 2004: Neuropsychiatric symptoms in carbon monoxide poisoning. Nihon Rinsho. Japanese Journal of Clinical Medicine 62 Suppl: 507-510
Xie, H.-g.; Wang, L.-n.; Yu, X.; Wang, W.; Yang, L.-j.; Ma, T.-x.; Zhang, X.-h.; Yang, L.-j.; Xu, X.-h.; Peng, D.-t.; Zhang, Z.-X.; Wei, J.; Wang, Y.-h.; Jia, J.-p.; Guan, X.-t.; Feng, F. 2004: Neuropsychiatric symptoms in dementia and elderly people in the community: results from the Beijing Dementia Cooperative Study. Zhonghua Liu Xing Bing Xue Za Zhi 25(10): 829-832
Artaso Irigoyen, B.; Goñi Sarriés, A.; Gómez Martínez, A.R. 2004: Neuropsychiatric symptoms in dementia syndrome. Revista de Neurologia 38(6): 506-510
Harvald, B.; Bjorneboe, M. 1958: Neuropsychiatric symptoms in liver insufficiency. Acta Medica Scandinavica 160(5): 373-384
Pollero, A.; Giménez, M.; Allegri, R.F.; Taragano, F.E. 2004: Neuropsychiatric symptoms in patients with Alzheimer disease. Vertex 15(55): 5-9
Dseplat-Jégo, S.; Bernard, D.; Bagnères, D.; Frances, Y. 2003: Neuropsychiatric symptoms in the elderly: let us not forget celiac disease. Journal of the American Geriatrics Society 51(6): 884-885
Louw, A. 1952: Neuropsychiatric symptoms in the general adaptation system. Ugeskrift for Laeger 114(22): 703-708
Tsiouris, J.A.; Brown, W.T. 2004: Neuropsychiatric symptoms of fragile X syndrome: pathophysiology and pharmacotherapy. Cns Drugs 18(11): 687-703
Harvald, B.; Bjorneboe, M. 1957: Neuropsychiatric symptoms of liver insufficiency. Ugeskrift for Laeger 119(45): 1451-1457
Małyszczak, K.; Inglot, M.łg.; Pawłowski, T.; Czarnecki, M.; Rymer, W.; Kiejna, A. 2006: Neuropsychiatric symptoms related to interferon alpha. Psychiatria Polska 40(4): 787-797
Senanarong, V.; Poungvarin, N.; Jamjumras, P.; Sriboonroung, A.; Danchaivijit, C.; Udomphanthuruk, S.; Cummings, J.L. 2005: Neuropsychiatric symptoms, functional impairment and executive ability in Thai patients with Alzheimer's disease. International Psychogeriatrics 17(1): 81-90
Rey Ardid, R.; Serrate Torrente, A. 1951: Neuropsychiatric syndrome of arteriosclerotic origin; clinical note. Clinica y Laboratorio 51(299): 127-130
Ferrell, R.B.; Wolinsky, E.J.; Kauffman, C.I.; Flashman, L.A.; McAllister, T.W. 2004: Neuropsychiatric syndromes in adults with intellectual disability: issues in assessment and treatment. Current Psychiatry Reports 6(5): 380-390
Zeman, W. 1951: Neuropsychiatric syndromes in sarcoidosis. Deutsche Medizinische Wochenschrift 76(51): 1621-1622
Abreu, M.R.; Jakosky, A.éi.; Folgerini, M.; Brenol, J.ão.C.T.; Xavier, R.M.; Kapczinsky, F.áv. 2005: Neuropsychiatric systemic lupus erythematosus: correlation of brain MR imaging, CT, and SPECT. Clinical Imaging 29(3): 215-221
Brey, R.L.; Petri, M.A. 2003: Neuropsychiatric systemic lupus erythematosus: miles to go before we sleep. Neurology 61(1): 9-10
Govoni, M.; Rizzo, N.; Castellino, G.; Padovan, M.; Trotta, F. 2005: Neuropsychiatric systemic lupus erythematosus: where are we now?. Reumatismo 57(4): 215-225
Montgomery, S. 2005: Neuropsychiatric testing for ADHD. Advance for Nurse Practitioners 13(11): 14
Perucca, E. 1999: Neuropsychiatric therapies. Idrugs: the Investigational Drugs Journal 2(12): 1269-1270
Blumenauer, G. 1952: Neuropsychiatric unit. Modern Hospital 78(3): 59-61
Delay, J.; Deniker, P.; Ginestet, D.; Verdeaux, G.; Verdeaux, J.; Rausch De Traubenberg, N.; Passelecq, J. 1962: Neuropsychiatric, psychometric and electroencephalographic study of subjects with congenital cardiac defects operated upon under deep hypothermia and extracorporeal circulation. Annales de Chirurgie Thoracique et Cardio-Vasculaire 1: 674-677
Drake, F.R. 1957: Neuropsychiatric-like symptomatology of Addison's disease: a review. American Journal of the Medical Sciences 234(1): 106-113
Chaitin, B.F. 2003: Neuropsychiatry. American Journal of Psychiatry 160(5): 1014; Author Reply 1015
Lindegard, B. 1958: Neuropsychiatry and traffic safety. Social-Medicinsk Tidskrift 35(9): 364-367
Lereboullet, J.; Escourolle, R. 1963: Neuropsychiatry in 1963. La Revue du Praticien 13: 3563-3594
Lereboullet, J.; Escourolle, R. 1964: Neuropsychiatry in 1964. La Revue du Praticien 14: 3313-3335
Heuyer, G.; Tramer, M. 1964: Neuropsychiatry Is in Mourning. Professor M. Tramer, 1882-1963. Revue de neuropsychiatrie infantile et d'hygiene mentale de l'enfance 12: 185-186
Lauras, A. 1960: Neuropsychiatry and corticotherapy. Epileptic complications and psychic disorders in adrenal cortex therapy. Rhumatologie 12: 258-267
Faulong, L. 1960: Neuropsychiatry and corticotherapy. Neurological accidents. Rhumatologie 12: 250-257
Verhoeven, W.M.A.; Feenstra, I.; Van Ravenswaay-Arts, C.; Egger, J.I.M.; Van Beurden, J.J.Th.M.; Tuinier, S. 2006: Neuropsychiatry and deletions of 18q; case report and diagnostic considerations. Genetic Counseling 17(3): 307-313
Brugger, P. 2003: Neuropsychiatry and parapsychology of autoscopic phenomena. Der Nervenarzt 74(3): 293-295
Baudouin, A. 1952: Neuropsychiatry in 1951. La Revue du Praticien 2(3): 131-141
Baudouin, A.; Schaeffer, H. 1953: Neuropsychiatry in 1952. La Revue du Praticien 3(12): 791-803
Baudouin, A. 1954: Neuropsychiatry in 1953. La Revue du Praticien 4(9): 755-770
Lereboullet, J.; Escourolle, R. 1960: Neuropsychiatry in 1960. La Revue du Praticien 10: 2889-2919
Lereboullet, J.; Escourolle, R. 1962: Neuropsychiatry in 1962. La Revue du Praticien 12: 881-913
Jelasic, F. 1960: Neuropsychiatry in Ceylon. Neuropsihijatrija 8: 97-103
Stensrud, P.A. 1955: Neuropsychiatry in Turkey. Nordisk Medicin 53(2): 79-80
Bouchal, M. 1962: Neuropsychiatry in Yugoslavia. Ceskoslovenska Psychiatrie 58: 283-288
Garrard, R.L. 1950: Neuropsychiatry in private practice. North Carolina Medical Journal 11(4): 200-205
Ventra, D. 1960: Neuropsychiatry in relation to the problems of security on the roads. Rassegna di Neuropsichiatria E Scienze Affini 15: 1-17
Jones, C.H. 1951: Neuropsychiatry in the Aleutian Islands. Diseases of the Nervous System 12(6): 172-177
Poenitz, K. 1960: Neuropsychiatry, psychiatry and neurology. A short historical retrospect and prospect. Psychiatrie Neurologie und Medizinische Psychologie 12: 281-284
Rosenberg, R. 2004: Neuropsychiatry--future psychiatry. The Danish Society of Psychiatry. Ugeskrift for laeger 166(12): 1119
Caldwell, J.M. 1951: Neuropsychiatry. Organization and administration in the Office of the Surgeon General, 1948-1951. United States Armed Forces Medical Journal 2(5): 827-832
Schiffer, R.B.; Bowen, B.; Hinderliter, J.; Hurst, D.L.; Lajara-Nanson, W.A.; Packard, R.C. 2004: Neuropsychiatry: a management model for academic medicine. Journal of Neuropsychiatry and Clinical Neurosciences 16(3): 336-341
Benon, R. 1958: Neuropsychiatry: dementia in aged. La Tunisie Medicale 36(3): 147-148 Passim
Hurwitz, T.A. 2004: Neuropsychiatry: grasping the body-mind and mind-body problems. Canadian Journal of Psychiatry. Revue Canadienne de Psychiatrie 49(3): 155-156
Gorman, J.M. 2001: Neuropsychiatry: now more than ever. Cns Spectrums 6(12): 947
Pena, J. 1959: Neuropsychic and bioelectrical development of a child with phenylketonuria. Revista Espanola de Pediatria 15(85): 45-56
Worms, R.; Clay, R.; Bachelier, C. 1965: Neuropsychic Complications Attributable to Colistin Methane Sulfonate. Bulletins et Memoires de la Societe Medicale des Hopitaux de Paris 116: 45-50
Bertone, E. 1965: Neuropsychic Complications Due to Subacute Poisoning with Carbon Monoxide. Minerva Medica 56: 1657
Boudin, G.; Lauras, A.; Ismail, B. 1964: Neuropsychic Manifestations in the Course of Idiopathic Hemochromatosis. Medecine Dans le Monde 40: 136-139
Gianotti, F.; Bubola, D.; Ronchi, E.; Dellabeffa, A. 1964: Neuropsychic Study of Patients with Pemphigus, Duhring's Polymorphous Dermatitis and Pemphigoids. Giornale Italiano di Dermatologia 105: 325-346
Gianotti, F.; Ronchi, E.; Bubola, D. 1963: Neuropsychic Study of the Mothers of Children with Grave Congenital Epidermolysis Bullosa. Giornale Italiano di Dermatologia 104: 505-514
Schaposnik, F.; Vazquez, S. 1963: Neuropsychic Syndrome Caused by Systemic Lupus in a 15-Year-Old Boy. Prensa Medica Argentina 50: 2946-2948
Lebourges, J. 1962: Neuropsychic accidents of chronic alcoholism: emergency problems. Clinique 57: 489-492
Stojiljkovic, S.S. 1954: Neuropsychic complications during 1953 epidemic of influenza. Srpski Arhiv Za Celokupno Lekarstvo 82(7-8): 952-957
Richet, G.; Ardaillou, R.; Sultan, Y. 1962: Neuropsychic complications in chronic uremic patients treated by colistin methanesulfonate. Bulletins et Memoires de la Societe Medicale des Hopitaux de Paris 113: 1199-1205
Jurcova, M.; Meszarosova, O. 1956: Neuropsychic development in children up to three years of age within a group environment. Ceskoslovenska Pediatrie 11(11): 832-836
Segagni, E. 1955: Neuropsychic disorders caused by chloramphenicol during paratyphoid B. Minerva Pediatrica 7(8): 219-223
Stefani, S. 1957: Neuropsychic disorders caused by cranial trauma in infants and adolescents. Rassegna di Neuropsichiatria e Scienze Affini 11(1-2): 73-96
Efendiev, T.M. 1956: Neuropsychic disorders in Botkin's disease. Terapevticheskii Arkhiv 28(8): 71-72
Uschakow, G.K. 1958: Neuropsychic disorders in Werlhof's disease. Zeitschrift für Arztliche Fortbildung 52(12): 499-504
Sutter, J.M. 1953: Neuropsychic disorders in left-handed children forces to use the right hand. Algerie Medicale 57(7): 647-649
Kosenko, Z.V.; Paramonova, E.G. 1959: Neuropsychic disorders in patients with coronary atherosclerosis. Klinicheskaia Meditsina 37: 72-78
Malis, G.I. 1957: Neuropsychic disorders in rheumatism. Sovetskaia Meditsina 21(5): 21-26
Escardo, F.; Mosovich, A.; Breyer, I. 1953: Neuropsychic factors in asthma in children. Revista Medica de Cordoba 41(5): 168-169
Mazzanti, L.; Fabiani, P. 1960: Neuropsychic fatigue evaluated with the reaction time of chronic alcoholics after ingestion of alcohol. Rassegna di Studi Psichiatrici 49: 647-653
Delmas-Marsalet, P.; Verdeau, J.; Loiseau 1954: Neuropsychic forms of carbon tetrachloride poisoning; a case of poisoning by a fire extinguisher. Archives des Maladies Professionnelles de Medecine du Travail et de Securite Sociale 15(1): 21-25
Bazgadze, T.B.; Zurabashvili, D.Z. 2006: Neuropsychic infringements and problem behaviour of teenagers. Georgian Medical News 137: 59-61
Cetingil, A.I.; Beler, B. 1951: Neuropsychic manifestations during chloromycetin therapy of typhoid fever. Turk Tip Cemiyeti Mecmuasi 17(4): 179-185
Pringuet 1959: Neuropsychic sequelae of acute dehydration caused by gastroenteritis in infants. Le Nourrisson 47: 151-167
Gigli, L. 1956: Neuropsychic symptoms in pemphigus vulgaris. Archivio Italiano di Dermatologia Sifilografia e Venereologia 28(3): 250-256
Cattan, R. 1952: Neuropsychic symptoms of colitis. Gazette Medicale de France 59(20): 1193-1197
Legnani, F. 1955: Neuropsychic syndromes related to alpinism; an attempt at classification. Rassegna Giuliana di Medicina 11(5): 160-162
Savicevic, M.; Popovic, M. 1957: Neuropsychical complications in acute poisoning with carbon monoxide. Srpski Arhiv Za Celokupno Lekarstvo 85(4): 411-417
Koch, J. 1952: Neuropsychical development of infant. Prakticky Lekar 32(6-7): 139-144
Escardo, F.; Mosovich, A.; Breyer, I. 1953: Neuropsychical factors in asthma in children. Archivos de Pediatria del Uruguay 24(1): 39-41
Buccini, G. 1955: Neuropsychical factors in etiopathogenesis of hyperthyroidism. Folia Endocrinologica; Mensile di Incretologia E Incretoterapia 8(4): 631-642
Roger, J.; Rance, A.M.; Poinso, R. 1955: Neuropsychical form of lupus erythematosus disseminatus. Revue Neurologique (Paris) 92(6): 591-593
Bonnefoy, J.; Elmaleh, H.; Fournier, E.; Klotz, H.P.; Saintsaen, M. 1956: Neuropsychogenic obesity and the problem of obesity; study of the antidiuretic activity of blood; pathogenic value. La Semaine des Hopitaux: Organe Fonde Par l'Association d'Enseignement Medical des Hopitaux de Paris 32(65): 3362-3371
Antypchuk, K.I. 2004: Neuropsychologic analysis of memory peculiarities in patients exposed to ionizing radiation as a result of the Chernobyl accident. Likars'ka Sprava 1: 8-11
Branca, B. 2006: Neuropsychologic aspects of post-traumatic headache and chronic daily headache. Current Pain and Headache Reports 10(1): 54-66
Goldberg, E.; Bougakov, D. 2005: Neuropsychologic assessment of frontal lobe dysfunction. Psychiatric Clinics of North America 28(3): 567-580; 578-579
Munno, D.; Caporale, S.; Zullo, G.; Sterpone, S.; Malfatto, A.; Zeme, S.; Pagni, C.A. 2007: Neuropsychologic assessment of patients with advanced Parkinson disease submitted to extradural motor cortex stimulation. Cognitive and Behavioral Neurology: Official Journal of the Society for Behavioral and Cognitive Neurology 20(1): 1-6
Lanca, M.; Jerskey, B.A.; O'Connor, M.G. 2003: Neuropsychologic assessment of visual disorders. Neurologic Clinics 21(2): 387-416
Hederos, C.-A. 2004: Neuropsychologic changes and inhaled corticosteroids. Journal of Allergy and Clinical Immunology 114(2): 451-452
Shin, M.-S.; Kim, Y.-H.; Cho, S.-C.; Kim, B.-N. 2003: Neuropsychologic characteristics of children with attention-deficit hyperactivity disorder (ADHD), learning disorder, and tic disorder on the Rey-Osterreith Complex Figure. Journal of Child Neurology 18(12): 835-844
Pueyo, R.; Junqué, C.; Vendrell, P. 2003: Neuropsychologic differences between bilateral dyskinetic and spastic cerebral palsy. Journal of Child Neurology 18(12): 845-850
Saunamäki, T.; Hänninen, R.; Suhonen, J. 2005: Neuropsychologic examination and rehabilitation of multiple sclerosis patients. Duodecim; Laaketieteellinen Aikakauskirja 121(5): 537-544
Doninger, N.A.; Fink, J.W.; Utset, T.O. 2005: Neuropsychologic functioning and health status in systemic lupus erythematosus: does ethnicity matter?. Journal of Clinical Rheumatology: Practical Reports on Rheumatic and Musculoskeletal Diseases 11(5): 250-256
Premkumar, P.; Sharma, T. 2005: Neuropsychologic functioning and structural MRi of the brain in patients with schizophrenia. Expert Review of Neurotherapeutics 5(1): 85-94
Williams, D.L.; Goldstein, G.; Minshew, N.J. 2006: Neuropsychologic functioning in children with autism: further evidence for disordered complex information-processing. Child Neuropsychology: a Journal on Normal and Abnormal Development in Childhood and Adolescence 12(4-5): 279-298
Binder, L.M.; Kindermann, S.S.; Heaton, R.K.; Salinsky, M.C. 1998: Neuropsychologic impairment in patients with nonepileptic seizures. Archives of Clinical Neuropsychology: the Official Journal of the National Academy of Neuropsychologists 13(6): 513-522
Sánchez Rodríguez, J.L.; Rodríguez álvarez, M. 2004: Neuropsychologic performance and depressed mood in sporadic late onset Alzheimer disease. Revista de Neurologia 38(7): 625-630
Anderson, S.W. 2003: Neuropsychologic rehabilitation for visuoperceptual impairments. Neurologic Clinics 21(3): 729-740
Sweeney, J.E. 1994: Neuropsychologic sequelae of non-impact head injury in an older male. Applied Neuropsychology 1(1-2): 15-23
Kemper, M.J.; Spartà, G.; Laube, G.F.; Miozzari, M.; Neuhaus, T.J. 2003: Neuropsychologic side-effects of tacrolimus in pediatric renal transplantation. Clinical Transplantation 17(2): 130-134
Fortuyn, J.D. 1964: Neuropsychological Aspects of the Nervous System. Nederlands Tijdschrift Voor de Psychologie en Haar Grensgebieden 19: 349-360
Rosselli Cock, M.; Matute Villaseñor, E.; Ardila Ardila, A.; Botero Gómez, V.E.; Tangarife Salazar, G.A.; Echevarría Pulido, S.E.; Arbelaez Giraldo, C.; Mejía Quintero, M.; Méndez Losado, L.C.; Villa Hurtado, P.C.; Ocampo Agudelo, P. 2004: Neuropsychological Assessment of Children: a test battery for children between 5 and 16 years of age. A Colombian normative study. Revista de Neurologia 38(8): 720-731
Dunbar, N.; Brew, B. 1997: Neuropsychological Dysfunction in HIV Infection:A Review. Journal of Neuro-Aids 1(3): 73-102
Karachristianou, S.; Bostantjopoulou, S.; Katsarou, Z.; Kazis, A. 2004: Neuropsychological EEG activation in patients with juvenile myoclonic epilepsy. Functional Neurology 19(3): 185-189
Graydon, F.J..X..; Nunn, J.A..; Polkey, C.E..; Morris, R.G.. 2001: Neuropsychological Outcome and the Extent of Resection in the Unilateral Temporal Lobectomy. Epilepsy and Behavior: E&b 2(2): 140-151
Lendt, M.; Gleissner, U.; Helmstaedter, C.; Sassen, R.; Clusmann, H.; Elger, C.E.. 2002: Neuropsychological Outcome in Children after Frontal Lobe Epilepsy Surgery. Epilepsy and Behavior: E&b 3(1): 51-59
Houdart, R.; Cathala, F.; Raby, D.; Vollmer, D. 1963: Neuropsychological Study of the Subjective Syndrome of Patients with Head Injuries. Bulletins et Memoires de la Societe Medicale des Hopitaux de Paris 114: 767-776
Pineda, D.; Ardila, A.; Rosselli, M. 1999: Neuropsychological and behavioral assessment of ADHD in seven- to twelve-year-old children: a discriminant analysis. Journal of Learning Disabilities 32(2): 159-173
Bará-Jiménez, S.; Vicuña, P.; Pineda, D.A.; Henao, G.C. 2003: Neuropsychological and behavioral profiles of children with attention deficit/hyperactivity disorder from cali, colombia. Revista de Neurologia 37(7): 608-615
Reynolds, C.R.; Hickman, J.A. 1989: Neuropsychological and behavioral sequelae of amitriptyline overdose in infancy. Archives of Clinical Neuropsychology: the Official Journal of the National Academy of Neuropsychologists 4(4): 371-380
Accorrà, D.; Mazzarini, L.; Girardi, P.; Ruberto, A.; Kotzalidis, G.D.; Tatarelli, R. 2004: Neuropsychological and behavioural assessment in Alzheimer's disease. Annali Dell'istituto Superiore di Sanita 40(4): 485-493
Gutiérrez, L.; Dávalos, A.; Pedraza, S.; García Sánchez, C.; Kulisevsky, J. 2003: Neuropsychological and behavioural impairments resulting from bilateral thalamic infarct. Neurologia 18(7): 404-408
Marlow, N.; Rose, A.S.; Rands, C.E.; Draper, E.S. 2005: Neuropsychological and educational problems at school age associated with neonatal encephalopathy. Archives of Disease in Childhood. Fetal and Neonatal Edition 90(5): F380-F387
Gouvier, W.D.; Pinkston, J.B.; Lovejoy, J.C.; Smith, S.R.; Bray, G.A.; Santa Maria, M.P.; Hammer, J.H.; Hilsabeck, R.C.; Smiroldo, B.; Bentz, B.; Browndyke, J. 2004: Neuropsychological and emotional changes during simulated microgravity: effects of triiodothyronine alendronate, and testosterone. Archives of Clinical Neuropsychology: the Official Journal of the National Academy of Neuropsychologists 19(2): 153-163
Rosen, H.J.; Narvaez, J.M.; Hallam, B.; Kramer, J.H.; Wyss-Coray, C.; Gearhart, R.; Johnson, J.K.; Miller, B.L. 2004: Neuropsychological and functional measures of severity in Alzheimer disease, frontotemporal dementia, and semantic dementia. Alzheimer Disease and Associated Disorders 18(4): 202-207
Mathias, J.L.; Beall, J.A.; Bigler, E.D. 2004: Neuropsychological and information processing deficits following mild traumatic brain injury. Journal of the International Neuropsychological Society: Jins 10(2): 286-297
Mathias, J.L.; Bigler, E.D.; Jones, N.R.; Bowden, S.C.; Barrett-Woodbridge, M.; Brown, G.C.; Taylor, D.J. 2004: Neuropsychological and information processing performance and its relationship to white matter changes following moderate and severe traumatic brain injury: a preliminary study. Applied Neuropsychology 11(3): 134-152
Rahmani, M.; Bennani, M.; Benabdeljlil, M.; Aidi, S.; Jiddane, M.; Chkili, T.; El Alaoui Faris, M. 2006: Neuropsychological and magnetic resonance imaging findings in five patients after carbon monoxide poisoning. Revue Neurologique (Paris) 162(12): 1240-1247
Wood, R.L.; Liossi, C. 2006: Neuropsychological and neurobehavioral correlates of aggression following traumatic brain injury. Journal of Neuropsychiatry and Clinical Neurosciences 18(3): 333-341
Twamley, E.W.; Ropacki, S.A.L.; Bondi, M.W. 2006: Neuropsychological and neuroimaging changes in preclinical Alzheimer's disease. Journal of the International Neuropsychological Society: Jins 12(5): 707-735
Hopkins, R.O.; Haaland, K.Y. 2004: Neuropsychological and neuropathological effects of anoxic or ischemic induced brain injury. Journal of the International Neuropsychological Society: Jins 10(7): 957-961
Tatebayashi, Y. 2004: Neuropsychological and neuropathological interactions in affective and cognitive geriatric syndromes. Nihon Shinkei Seishin Yakurigaku Zasshi 24(5): 273-277
Cartier, L.; Passig, C.; Gormaz, A.; López, J. 2002: Neuropsychological and neurophysiological features of Fahr's disease. Revista Medica de Chile 130(12): 1383-1390
Gschwandtner, U.; Aston, J.; Borgwardt, S.; Drewe, M.; Feinendegen, C.; Lacher, D.; Lanzarone, A.; Stieglitz, R.-D.; Riecher-Rössler, A. 2003: Neuropsychological and neurophysiological findings in individuals suspected to be at risk for schizophrenia: preliminary results from the Basel early detection of psychosis study - Früherkennung von Psychosen (FEPSY). Acta Psychiatrica Scandinavica 108(2): 152-155
Bodis-Wollner, I. 2003: Neuropsychological and perceptual defects in Parkinson's disease. Parkinsonism and Related Disorders 9(Suppl 2): S83-S89
Beglinger, L.J.; Duff, K.; Van Der Heiden, S.; Moser, D.J.; Bayless, J.D.; Paulsen, J.S.; Gingrich, R. 2007: Neuropsychological and psychiatric functioning pre- and posthematopoietic stem cell transplantation in adult cancer patients: a preliminary study. Journal of the International Neuropsychological Society: Jins 13(1): 172-177
Ciesielski, A.-S.; Samson, S.év.; Steinhoff, B.J. 2006: Neuropsychological and psychiatric impact of add-on titration of pregabalin versus levetiracetam: a comparative short-term study. Epilepsy and Behavior: E&b 9(3): 424-431
Sader, M.A.; Miller, L.A.; Caine, D.; McCredie, R.J.; Corr, M.J.; Robertson, M.; Watson, J.D.G.; Celermajer, D.S. 2002: Neuropsychological and psychiatric outcomes following coronary surgery or angioplasty: a comparative study. Heart Lung and Circulation 11(2): 95-101
Northam, E.A. 2004: Neuropsychological and psychosocial correlates of endocrine and metabolic disorders--a review. Journal of Pediatric Endocrinology and Metabolism: Jpem 17(1): 5-15
Bellinger, D.C.; Trachtenberg, F.; Barregard, L.; Tavares, M.; Cernichiari, E.; Daniel, D.; McKinlay, S. 2006: Neuropsychological and renal effects of dental amalgam in children: a randomized clinical trial. JAMA 295(15): 1775-1783
Thoma, R.J.; Hanlon, F.M.; Miller, G.A.; Huang, M.; Weisend, M.P.; Sanchez, F.P.; Waldorf, V.A.; Jones, A.; Smith, A.; Formoso, M.J.; Cañive, J.M. 2006: Neuropsychological and sensory gating deficits related to remote alcohol abuse history in schizophrenia. Journal of the International Neuropsychological Society: Jins 12(1): 34-44
White, J.L.; Moffitt, T.E.; Silva, P.A. 1992: Neuropsychological and socio-emotional correlates of specific-arithmetic disability. Archives of Clinical Neuropsychology: the Official Journal of the National Academy of Neuropsychologists 7(1): 1-16
Földi, R.; Tomasovszki, L.ás.ó 2003: Neuropsychological applications of the Rey complex figure and recognition test. Ideggyogyaszati Szemle 56(3-4): 82-91
Semrud-Clikeman, M. 2005: Neuropsychological aspects for evaluating learning disabilities. Journal of Learning Disabilities 38(6): 563-568
Bömmer, I.; Brüne, M. 2007: Neuropsychological aspects of delusional disorders. Characteristic attributional style or cognitive deficit?. Der Nervenarzt 78(7): 796-801
Lundqvist, A.; Alinder, J.; Alm, H.; Gerdle, B.; Levander, S.; Rönnberg, J. 1997: Neuropsychological aspects of driving after brain lesion: simulator study and on-road driving. Applied Neuropsychology 4(4): 220-230
Helmstaedter, C. 2004: Neuropsychological aspects of epilepsy surgery. Epilepsy and Behavior: E&b 5(Suppl 1): S45-S55
Fazekas, J.F.; Alman, R.W. 1961: Neuropsychological aspects of hyperorexia and anorexigenic agents. Practitioner 187: 566-573
Jokeit, H.; Schacher, M. 2004: Neuropsychological aspects of type of epilepsy and etiological factors in adults. Epilepsy and Behavior: E&b 5(Suppl 1): S14-S20
Nies, K.J.; Sweet, J.J. 1994: Neuropsychological assessment and malingering: a critical review of past and present strategies. Archives of Clinical Neuropsychology: the Official Journal of the National Academy of Neuropsychologists 9(6): 501-552
Jacobsen, S.E.; Sprenger, T.; Andersson, S.; Krogstad, J-Magne. 2003: Neuropsychological assessment and telemedicine: a preliminary study examining the reliability of neuropsychology services performed via telecommunication. Journal of the International Neuropsychological Society: Jins 9(3): 472-478
Hart, R.P.; Anderson, J.; Calabrese, V. 1996: Neuropsychological assessment in a case of pseudoneurologic symptamology. Applied Neuropsychology 3(1): 8-14
Havet, V. 2006: Neuropsychological assessment in amyotrophic lateral sclerosis. Revue Neurologique (Paris) 162(Special Issue 2): 4s151-4s157
Lowe, M.; Harris, W.; Kane, R.L.; Banderet, L.; Levinson, D.; Reeves, D. 2007: Neuropsychological assessment in extreme environments. Archives of Clinical Neuropsychology: the Official Journal of the National Academy of Neuropsychologists 22(Suppl 1): S89-S99
Slick, D.J.; Craig, P.L. 1991: Neuropsychological assessment in public psychiatric hospitals: the changing state of the practice-1979 to 1989. Archives of Clinical Neuropsychology: the Official Journal of the National Academy of Neuropsychologists 6(1-2): 73-80
Borkowska, A.; Sobów, T. 2005: Neuropsychological assessment in the diagnosis and differential diagnosis of fronto-temporal dementia. Neurologia i Neurochirurgia Polska 39(6): 466-475
Kienle, X.; Thumser, K.; Saile, H.; Karch, D. 2005: Neuropsychological assessment of ADHD subtypes. Praxis der Kinderpsychologie und Kinderpsychiatrie 54(3): 159-172
Wong, T.M.; Fujii, D.E. 2004: Neuropsychological assessment of Asian Americans: demographic factors, cultural diversity, and practical guidelines. Applied Neuropsychology 11(1): 23-36
Müller, B.W.; Gimbel, K.; Keller-Pliessnig, A.; Sartory, G.; Gastpar, M.; Davids, E. 2007: Neuropsychological assessment of adult patients with attention-deficit/hyperactivity disorder. European Archives of Psychiatry and Clinical Neuroscience 257(2): 112-119
Sjøgren, P.; Christrup, L.L.; Petersen, M.A.; Højsted, J. 2005: Neuropsychological assessment of chronic non-malignant pain patients treated in a multidisciplinary pain centre. European Journal of Pain 9(4): 453-462
Plumet, J.; Gil, R.; Gaonac'h, D. 2005: Neuropsychological assessment of executive functions in women: effects of age and education. Neuropsychology 19(5): 566-577